Colloidal Upconverting Nanoparticle Systems for Integration in Targeting, Therapeutics and Imaging Applications by Naccache, Rafik
Colloidal Upconverting Nanoparticle Systems for Integration in Targeting, Therapeutics 































Presented in Partial Fulfillment of the Requirements 
for the Degree of Doctorate of Philosophy at 
Concordia University 









© Rafik Naccache, 2012 
CONCORDIA UNIVERSITY  
SCHOOL OF GRADUATE STUDIES 
 
This is to certify that the thesis prepared 
 
By:  Rafik Naccache 
 
Entitled: Colloidal Upconverting Nanoparticle Systems for Integration in  
 




and submitted in partial fulfillment of the requirements for the degree of 
 
      Doctorate of Philosophy (Chemistry)  
 
complies with the regulations of the University and meets the accepted 
standards with respect to originality and quality. 
 
Signed by the final examining committee: 
 
Chair 
   

























Dean of Faculty 
Dr. A. Radomsky 
Dr. J. Claverie 
Dr. B. Woodside 
Dr. H. Muchall 
Dr. L. Cuccia 




Colloidal Upconverting Nanoparticle Systems for Integration in Targeting, 
Therapeutics and Imaging Applications 
 
 
Rafik Naccache, Ph.D. 
Concordia University, 2012 
 
 The synthesis and surface modification of sodium gadolinium fluoride 
(NaGdF4:Er3+/Tm3+, Yb3+) nanoparticles were investigated for potential integration in 
biological applications. These nanoparticles are poised to replace conventional 
fluorophores in targeting, imaging and therapeutic applications. The latter possess several 
shortcomings ranging from photobleaching to requirements for ultraviolet (UV) 
excitation. In contrast, these nanoparticles are optically robust and may be excited using a 
near infrared (NIR) light source, which can be converted to UV, visible or NIR light via 
upconversion. Near infrared light is advantageous as it offers greater tissue penetration 
depth relative to UV or visible light and does not harm cells.  
 Colloidal upconverting nanoparticles were synthesized using thermal 
decomposition. Synthetic parameters such as reaction temperature (280-320 °C), time 
(30-180 min) and precursor addition rates (0.5-2.5 mL/min) were used to tailor the 
nanoparticle morphology, crystal phase (cubic or hexagonal) and particle size (10-80 
nm). Integration of these nanoparticles in biological applications requires dispersibility in 
aqueous media. Hence several strategies such as silica shell coating and ligand exchange 




 Orthogonal surface functionalization with amino and azido silane reagents was 
carried out on silica coated nanoparticles allowing for surface decoration using a cancer 
targeting folic acid derivative and a cis-platinum precursor therapeutic agent. The folate 
derivative was functionalized to the nanoparticle surface using "click" chemistry via 
surface N3 groups, while the cis-platinum derivative formed a coordination bond with the 
surface NH2 groups in a one-pot, one-step approach. The nanoparticle system was 
tri-modal with targeting, imaging and therapeutic capacities. 
 These luminescent upconverting NaY(Gd)F4:Tm3+/Yb3+ nanoparticles were 
investigated as novel contrast agents in magnetic resonance imaging. Hydrophilic 
citrate-capped colloidal nanoparticles showed strong T1 enhancement effects. Positive 
contrast enhancement was observed at Gd3+ host concentrations as low as 5 mol%. The 
5-nm sized nanoparticles produced similar contrast enhancement to current clinical 
gadolinium chelates with the added advantage that toxic Gd3+ leaching is not a concern as 
the ions are tightly bound in the crystal. 
 These nanoparticles have been developed into multimodal systems, which may be 
used in cancer diagnostic and therapeutic applications as well as in whole body magnetic 
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Chapter 1 - Introduction 
1.1 A "Nano" Idea with a Macro Potential 
 In a speech entitled “There is plenty of room at the bottom” given at the annual 
meeting of the American Physical Society in 1959 at the California Institute of 
Technology, Richard Feynman discussed the idea of miniaturization of technology and 
applications beyond the resolution of the naked eye. Feynman envisioned the 
miniaturization of engines, the building of progressively smaller molecular factories up to 
the idea of the manipulation of individual atoms and molecules [1]. While his inspiring 
speech resonated within the minds of scientists on a global scale, it wasn't until 1981 that 
the first article was published by K. Eric Drexler, in which he expanded on the ideas of 
Feynman using the then-modern scientific concepts [2]. The appearance of Drexler's 
article sparked one of the most intense research pursuits within the scientific community 
as many scientists recognized the importance of being "small-minded" in achieving the 
tremendous potential of miniaturization and its underlying impact. In fact, in the last 
twenty years, scientists from all domains have diligently worked on the development of 
nanoscience and nanotechnology. Nanoscience does not solely concern itself with the 
development of novel materials and technologies, but also seeks to bring forth 
improvements and enhancements to already existing ones. The properties at the nanoscale 
can change significantly relative to the bulk domain. For example, as the particle size is 
reduced and enters the nano-regime (< 100 nm in one dimension), the surface area to 
volume ratio increases significantly and imparts very interesting properties to the 
materials (Figure 1.1). Hence, a departure from the micrometer domain to its nanometer 
2 
 
counterpart offers new possibilities that could enhance current products and technologies, 




Figure 1.1. The increase in surface area-to-volume ratio as a result of particle size 
reduction. Here a single cube can be subdivided into 125 equal smaller cubes of reduced 
dimensions to yield a 5-fold increase in the surface area to volume ratio. 
 
 
 In light of their interesting properties at the nanoscale, nanoparticles have been 
integrated in a myriad of industries. For example, in the textile industry, nanoparticles 
have found widespread use via a process known as "nanofinishing", which allows for the 
introduction of several desirable properties in a garment. In one case, nanoparticles can 
be used to add a UV protective layer that can shield the individual's skin from harmful 
UV rays. In another case, nanoparticles can be used to generate wrinkle free, stain 
resistant, hypo-allergenic, or anti-bacterial garments [3, 4].  
Cube
Dimensions = 250 nm
Individual Cube
Dimensions = 50 nm
Surface Area (nm2) 3.8x105 1.9x106
Volume (nm3) 15.6x106 15.6x106
Surface Area to 
Volume Ratio 0.6 3.0
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 The automobile industry has not remained idle and has taken several steps 
towards the incorporation of nanomaterials in their product lineups. Studies 
commissioned by several European Union member countries came to the 
recommendation in 2006 that nanomaterials can be beneficial in various sectors of the 
automotive industry especially in the development of vehicle frames, body components 
and parts, engines and power trains, chip-resistant paints, suspension and breaking 
systems, lubrication, tires, exhaust systems and catalytic converters [5]. The changes in 
the physico-chemical properties as the materials enter into the nano regime render them 
stronger, more secure and resistant to wear and tear. 
 Another area where nanomaterials are slated to cause a large impact is in the field 
of environmental safety and eco-system cleanup and monitoring. As a byproduct of an 
industrial, product/consumer-driven society, many of the eco-systems around the world 
are being destroyed and polluted, most notably water-based resources such as oceans, 
rivers and lakes. These resources provide drinking-water, food and are used for 
agricultural development where much of the contamination generated by industry may 
seep into the deep soil. This has a direct consequence on housing and agriculture 
practices as these pollutants can have a tremendous negative impact on the health of 
humans, animals and plants. As such, it is critical to develop novel materials that can be 
used in efficient decontamination processes. Due to their high surface area to volume 
ratio, nanoparticles have been touted as excellent tools for remediation of contaminated 
materials and development of environmental sensors [6]. Much of the current research 
has focused on the use of self-assembled monolayers on mesoporous supports, which 
offers surface areas upwards of 1000 m2/g resulting in elevated contaminant adsorption. 
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Other works have focused on the synthesis of nanoporous materials functionalized with 
polymers or other organic entities in water treatment and soil washing applications, for 
the binding of heavy metals such as copper (II), lead (II), and palladium (II) to name a 
few [7-9].  Lastly, nano-sized zero-valent iron particles are now being commercialized for 
the degradation of certain contaminants such as polychlorinated biphenyls and carbon 
tetrachloride [6]. These few examples demonstrate concrete cases regarding the important 
role that nanoscience and nanotechnology have played and will continue to play in 
everyday life. 
 
1.2 The Promise of Nanoscience in Biomedical Applications 
 With the increase in numbers of an aging population and the requirement for more 
efficient health care, scientists have looked to develop novel and more powerful 
biomedical tools that can address increasing health and patient needs. Nanomaterials and 
nanotechnology are envisioned to have a large impact in biomedicine especially for 
imaging, diagnostics and therapeutics. Efforts have been geared towards the development 
of novel and non-invasive techniques for rapid disease detection, early intervention and a 
greater probability of therapeutic success. Of particular interest are luminescent 
nanoparticles, which due to their optical properties, may be used for in vitro and in vivo 
imaging applications (optical and magnetic imaging). Furthermore, luminescent 
nanoparticle-based systems are also touted as being ideal candidates for the development 
of multimodal platforms allowing for the integration of additional functionalities 
(targeting or therapeutic for example). These luminescent probes can be divided in two 
main categories namely organic fluorophores and inorganic nanomaterials. 
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1.2.1 Organic Fluorophores 
 
 Organic fluorophores (dyes) are molecular in nature and hence are not defined as 
nanomaterials; however, they have been extensively used as fluorescent labels in 
conventional imaging techniques. While dye-based imaging yields acceptable results, it is 
usually limited in detection power due to a process known as autofluorescence, whereby 
both the analyte and the surrounding environment are concomitantly excited resulting in 
multiple emissions and limited detection sensitivity [10, 11]. Another significant problem 
related to the use of organic dyes lies in the fact that organic molecules tend to undergo 
photobleaching (or photodegradation) over a period of time due to the interaction with 
the excitation radiation (typically UV light) [12]. As the organic fluorophore degrades 
with time (over the course of the analysis), its optical response deteriorates resulting in 
decreased detection sensitivity and reliability. With respect to targeting and drug delivery, 
organic fluorophores lack the structure necessary to develop a scaffold system capable of 
multi-modal functionalities such as diagnostics and therapeutics. Furthermore, as will be 
discussed in section 1.2.2 (vide infra), the requirement for UV excitation renders them 
unattractive for use in in vivo imaging applications. 
 
1.2.2 Quantum Dot Nanoparticles 
 
 With the emergence of nanomaterials, much of the recent work over the last two 
decades has focused on alternatives to organic dye-fluorescent labels and principally on 
quantum dots (QDs). Quantum dots are inorganic semiconductors with electronic 
properties that are deemed to fall in between the bulk and molecular phases. These nano-
scaled inorganic materials are typically composed of groups II–VI or III–V elements 
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(CdSe or CdTe for example). Quantum dots possess unique optical properties, which 
stem from the fact that their physical dimensions (typically 2-10 nm) are smaller than the 
exciton Bohr radius [13]. Excitation using a photon of light promotes some of the 
electrons, in the valence band gap, to higher excited energy states, in the conduction band 
gap. Upon de-excitation and the return of an electron to its ground state, a photon of a 
frequency equivalent to the band gap is emitted. As the QD size changes so does the band 
gap separation energy meaning that the optical properties are directly related to the QD 
size. This is known as the quantum confinement effect [14]. While quantum dots do offer 
several advantages relative to organic dyes, such as narrower emission profiles, UV to IR 
emission, and resistance to photobleaching, they do suffer from several shortcomings. 
Firstly, they require wavelengths shorter than 530 nm (CdSe for example) as the principal 
source of excitation [13]. This represents a major challenge for in vivo imaging where 
deep tissue probing would require exciting the QD at several mm to cm below the 
subcutaneous surface. Ultraviolet and visible excitation sources do not possess high 
penetration depths as they are prone to Rayleigh and Mie scattering brought about by the 
presence of the tissue, water, plasma and cells, etc. While some QDs may be excited in 
the NIR, they typically require large and expensive femtosecond pulsed laser 
installations. Secondly, cytotoxicity remains a significant issue when considering 
quantum dots [15-19]. Heavy-metal based QDs are prone to degradation and the potential 
release of ions (such as cadmium for example), which are highly toxic. Hence, a safer and 




1.2.3 Lanthanide-Doped Nanoparticles 
 
 In the past decade, lanthanide-doped (Ln-doped) nanoparticles have emerged as 
an attractive alternative to current imaging probes. Unlike organic dyes, they do not 
suffer from photobleaching hence the optical signal measured throughout the course of an 
analysis remains constant. Unlike semiconducting QDs, lanthanide-doped inorganic 
nanoparticles are insulators implying that they possess an extremely wide band gap 





Figure 1.2. An illustration of the differences in band gap between conductors, 

















 A change in size of these Ln-doped nanoparticles does not impart drastic changes 
in their luminescence behaviour, which typically yields a varying spectrum of emission 
colours in QDs. Instead, size-related effects result in changes to the crystal phase, 
morphology or the extent of surface defects [21]. The luminescent behavior can be 
tailored to emit from the UV to the IR region of the electromagnetic spectrum via dopant 
selection and concentration.  
 Generally, luminescent probes rely on single photon excitation using UV light 
(high energy light) resulting in emissions at lower energies (known as Stokes emission). 
Multi-photon luminescence may be possible with dyes or QDs; however, it requires a 
very high photon density as opposed to lanthanide ions. The latter can be excited using 
NIR light (low energy) and emit in the UV, VIS or NIR regions (higher energy light 
known as anti-Stokes emission) using low power densities [22]. This multiphoton process 
is known as upconversion. With respect to biologically oriented, and especially in vivo, 
applications upconversion is highly interesting [23-26] as it can circumvent the 
requirement for UV or visible light as principle sources of excitation of the optical probe. 
In addition, NIR light does not excite the surroundings virtually eliminating 
autofluorescence. Furthermore, in contrast to UV light, NIR light offers significantly 
better penetration depth in tissue systems [27], does not impart damage to the sample 
under study and is less prone to scattering. Unlike most other two-photon absorption 
(TPA) materials where emission occurs via “virtual” excited states, excitation of Ln3+ 
ions such as Er3+ or Tm3+ proceeds via “real” electronic states of long lifetimes and thus 
high power, ultrafast lasers are not required for efficient excitation. In fact excitation can 
be carried out using commercially available cheap continuous wave NIR diodes. 
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Lanthanide-doped nanoparticles therefore offer a significant advantage relative to current 
imaging probes and may offer a succinct advantage in biologically-oriented applications. 
 
1.3 Statement of the Problem 
 Nanoscience and nanotechnology offer a huge promise in areas of biological and 
biomedical applications and are poised to play a signifcant role allowing for rapid 
diagnosis, detection and therapeutics with the ultimate goal of improving patient care and 
increasing chances of survival (considering diseases such as cancer for example). In 
many areas of disease research, there exists a need to achieve lower detection levels far 
superior to current techniques. Furthermore, there exists a need to develop a specific 
targeting mechanism towards treatment in order to overcome the numerous painful 
side-effects that patients experience and endure. Moreover, there also exists a need to 
achieve the aforementioned requirements using minimal invasive procedures relying on 
treatment platforms that are multi-modal (functional) capable of harvesting a multitude of 
information, relaying the information back and executing a therapeutic option. 
Nanoparticles offer the possibility for the development of such platforms.  
 The majority of Ln3+-doped nanoparticles, studied in the literature, are 
hydrophobic [28-34] and cannot be easily integrated into aqueous media. In order to 
allow for integration in biological applications, the nanoparticles need to be in a colloidal 
form implying that the nanoparticle's surface (or the molecules coordinating the 
nanoparticle surface) should either be hydrophilic or at least amenable to modification 
allowing for a facile dispersion in biorelevant media. Furthermore, the ability to integrate 
these nanoparticles into the imaging and biomedical fields remains dependent on the 
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ability to functionalize the nanoparticle surface with suitable recognition molecules, thus 
allowing for the development of biosensors as well as detection and diagnostic tools. 
 In the work reported herein, the synthesis of Ln3+-doped fluoride nanoparticles, 
via thermal decomposition, was thoroughly studied and systematically optimized in an 
effort to generate monodisperse upconverting nanoparticles. Particular emphasis was 
placed on identifying key reaction conditions and parameters, which would lead to a 
mechanism of control allowing for the tailoring of the nanoparticle size, morphology and 
crystal phase. Robust surface modification techniques such as ligand exchange and silica 
coating were also evaluated and used to modify the hydrophobic character of the 
nanoparticles rendering them water-dispersible. An orthogonal surface modification 
approach was developed to generate multi-functionalized surfaces for the subsequent and 
concomitant decoration of an organic cancer targeting ligand (folic acid) and inorganic 
therapeutic agent (cis-platinum). These multimodal fluoride nanoparticles were also 
investigated for potential use as contrast agents in magnetic resonance imaging (MRI) 
applications. Detailed studies of the effect of the gadolinium concentration and 
nanoparticle size on the relaxivity parameters were undertaken to develop an optimum 








Chapter 2 - Theory 
2.1 The Lanthanides 
 The discovery of the first lanthanide was made in 1794 by Johann Gadolin who 
succeeded in obtaining an oxide "earth" of a mineral later on to be called gadolinite while 
the earth was called yttria. Subsequently over the next few hundred years, additional 
"earth" oxides such as ceria and didymia were discovered. These earths were separated 
into various oxides of the elements, which at the time, earned the moniker "rare earths". 
While to this day, this term is used to refer to the lanthanides (along with yttrium and 
scandium), it is in fact a misnomer. The elements of the lanthanide series, with the 
exception of the radioactive (and man-made) promethium, are quite abundant. For 
example, cerium has a similar crustal concentration to nickel and copper. Thulium and 
lutetium, the rarest of the lanthanides, are more abundant than bismuth, silver or platinum 
[35]. Throughout this manuscript, the term "lanthanides" (or Ln) will be used to refer to 
the elements in question. The lanthanides are the group of elements occupying the sixth 
row of the periodic table starting from element 51 (lanthanum) to 71 (lutetium). While 
scandium and yttrium are not part of the lanthanide series, they are usually considered 
lanthanide-like or "lanthanoides" due to the similarity in their chemical properties and 
their occurrence in the same ores as the other elements of the lanthanides. 
 The lanthanides have the core electronic configuration [Xe] 6s2 5d1. A summary of 





Table 2.1. Electronic configuration of the lanthanide atoms as well as the ions in the 3+ 
oxidation state [35-37]. 
Atom Electronic Configuration 
Electronic Configuration 
3+ Oxidation State (Ln3+) 
   
Sc [Ar] 3d1 5s2 [Ar] 
Y [Kr] 4d1 5s2 [Kr] 
La [Xe] 5d1 6s2 [Xe] 
Ce [Xe] 4f1 5d1 6s2 [Xe] 4f1  
Pr [Xe] 4f3 6s2 [Xe] 4f2 
Nd [Xe] 4f4 6s2 [Xe] 4f3 
Pm [Xe] 4f5 6s2 [Xe] 4f4 
Sm [Xe] 4f6 6s2 [Xe] 4f5 
Eu [Xe] 4f7 6s2 [Xe] 4f6 
Gd [Xe] 4f7 5d1 6s2 [Xe] 4f7 
Tb [Xe] 4f9 6s2 [Xe] 4f8 
Dy [Xe] 4f10 6s2 [Xe] 4f9 
Ho [Xe] 4f11 6s2 [Xe] 4f10 
Er [Xe] 4f12 6s2 [Xe] 4f11 
Tm [Xe] 4f13 6s2 [Xe] 4f12 
Yb [Xe] 4f14 6s2 [Xe] 4f13 
Lu [Xe] 4f14 5d1 6s2 [Xe] 4f14 
   
 
 
 While some of the lanthanides may exist in the +2 and +4 oxidation states, the 3+ 
oxidation state is the most prevalent and is generally known to be the most stable 
configuration for the lanthanide ions. This stems from the fact that the +3 oxidation state 
leaves the ions in the [Xe] 4f x configuration and the ionization energy of the f electrons 
is so large, that they are considered core-like. This measure of stability also implies that 
modification via chemical means is highly difficult. The poor nuclear charge shielding 
behaviour of the f electrons occurs due to the fact that the 6s and 5d electrons are drawn 
closer towards the nucleus resulting in the well-known lanthanide contraction effect. The 
f-electrons are the poorest with respect to shielding, while the s-electrons are the best 
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[38]. The 5s2 and 5p6 electrons penetrate the f-subshell and as the nuclear charge 
increases, an increase in the contraction is also observed. The shielding of the f-electrons 
by their s and p counterparts has a direct impact on the magnetic and spectroscopic 
properties especially in the fact that they are highly uninfluenced by the ligands 
coordinating the lanthanide atoms. In addition, the crystal field splitting is significantly 
less in comparison to that of the d-block elements. As a result, the bands in the electronic 
spectra of the lanthanides are very sharp showing narrow emission profiles. Prior to 
discussing the optical properties of the lanthanides with a principal focus on the process 
of upconversion, it is appropriate to briefly cover the electronic structures and the crystal 
field theory, derivations of the energy levels and the selection rules that govern the 
occurrence of a given transition. 
 
2.1.1 The Free Energy Hamiltonian 
 
 Apart from the 4f shells, all other complete electronic shells are considered as a 
charge distribution with spherical symmetry. Therefore, their contribution to the relative 
positions of the 4f energy levels is negligible. The Hamiltonian that can be used to 
describe the 4f energy levels may therefore be written as follows [39, 40], 
 










l𝒊          (Equation 2.1)  
 
where N = 1 to 14 and represents the number of the f-electrons in the lanthanide series. 
The Hamiltonian operator in Equation 2.1 is comprised of four major terms. The first 
term is used to describe the sum of the electron kinetic energy and is the momentum 
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operator Δ𝑖 for the ith electron, while the second terms describes the electron-nuclear 
(coulombic) attraction. It contains the 𝑍∗𝑒2  term representing the screened nuclear charge 
and the term 𝑟𝑖, which is the distance between electron i and the nucleus. The second term 
in the Hamiltonian is necessary as the contribution of the spherically symmetrical 
electronic shells was defined above as negligible due to its minimal contribution. The 
third term is a repulsion term due to the electrostatic repulsion forces between electrons i 
and j, which are separated by distance r. Lastly, the fourth term describes the spin-orbit 
coupling, which is an electromagnetic interaction between the electron spin and the 
magnetic field created by the electron motion. In this last term, si .li describes the spin and 
orbital angular momentum contributions, respectively [39]. The 𝜁(𝑟𝑖) term in the fourth 
part of the Hamiltonian represents the spin-orbit coupling function. In its current form, it 
is simplified and may be expanded as follows, 
 
𝜁(𝑟𝑖) =  ℏ22𝑚2𝑐2𝑟𝑖 𝑑𝑈(𝑟𝑖)𝑑𝑟𝑖           (Equation 2.2) 
 
where 𝑈(𝑟𝑖) is the potential in which the ith electron is moving. The first two terms of the 
Hamiltonian operator are spherically symmetric and do not remove any of the 
degeneracies within the configuration of the f-orbitals. The term in Equation 2.1 can 








l𝒊          (Equation 2.3) 
 
 
and for simplicity during discussion, while referring to the remaining coulombic 
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repulsion and spin-orbit coupling terms, the Hamiltonian will be further simplified and 
expressed as follows, 
 
ℋ =  ℋ𝑐 + ℋ𝑠𝑜          (Equation 2.4) 
 
where ℋ𝑐 and ℋ𝑠𝑜 are the coulombic repulsion and spin orbit coupling components of 
the Hamiltonian, respectively [39]. Equation 2.4 can be further reduced depending on the 
magnitude of the atomic number. For example, in the case of Z ≈ 30, i.e. light atoms, the 
ℋ𝑠𝑜 term is small in comparison to its coulombic repulsion counterpart and may be 
regarded as a perturbation. In this situation, the total orbital angular momentum, L, and 
total spin angular momentum, S, are sufficient for the classification of the energy levels 
(Russell-Saunders or LS scheme). In the opposite case, where Z is representative of heavy 
atoms, the L and S quantum numbers are not suitable to describe the energy levels since 
spin-orbit coupling is strong in comparison to coulombic repulsion. Instead, the total 
angular momentum J, defined as the sum of the individual total angular momenta j, is 
used ( j-j coupling scheme) [36, 41]. 
 
2.1.1.1 The Russell Saunders Coupling Scheme 
 
 In the Russell Saunders coupling scheme, the values of L and S must first be 
calculated. This is achieved by summing up all the s and l values of the individual 
electrons in order to obtains the S and L terms, respectively. The addition of the spin 
quantum numbers (s) of the individual electrons yields a value for S according to 
equation 2.5,  
𝑆 = 𝑠1 + 𝑠2 + 𝑠3 + ⋯           (Equation 2.5) 
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Similarly, adding the orbital angular momentum quantum numbers (l) of the individual 
electrons yields a value for L according to Equation 2.6, 
 
𝐿 = 𝑙1 + 𝑙2 + 𝑙3 + ⋯           (Equation 2.6) 
 
Once the S and L terms are calculated, the value for J can also be obtained. If the orbital 
is less than half-filled, then J = L - S and if the orbital is more than half-filled, then the 
expression is written as J = L + S. If the orbital is exactly half-filled, then L = 0 and J = S. 
These three terms provide the Russell Saunders term symbol, which can be used to 
describe the energy levels in an atom as 2S+1LJ, where 2S+1 is the spin multiplicity, which 
obeys the Pauli exclusion principle. The ground state for the energy levels follows Hund's 
rule, which essentially requires this state to have the largest values of both S and L [36, 
39-41]. 
 
2.1.1.2 The j-j Coupling Scheme 
 
 When dealing with heavier atoms, where a larger nuclear charge is present, the 
interactions between the orbital angular momenta, j, of the individual electrons is equally 
strong compared to the spin-orbit interactions between the spin and the orbital angular 
momentum [41, 42]. In this case, the individual j value for the individual electrons must 
first be determined through the coupling of the individual l and s values as follows,  
 
𝑗1 = 𝑙1 + 𝑠1 
𝑗2 = 𝑙2 + 𝑠2 





Both schemes are applicable in the case of the lanthanides; however, there is a general 
preference towards the use of the Russell Saunders coupling as it yields satisfactory 
results. In many cases, an intermediate coupling scheme combining both the Russell 
Saunders and j-j coupling schemes may also be employed. The term symbols for the 
energy levels of the lanthanides are derived via the coupling schemes discussed above. In 
fact this work was carried out by Dieke in 1968 [43] and is shown in Figure 2.1 below. 
 
 




2.1.2 The Crystal Field 
 
 In a free lanthanide ion (Ln3+), the electrons move/rotate freely. This is not 
necessarily the case in a crystal. In this situation, the ligands coordinated to the ion 
possess an electron distribution, which disturbs the movement/rotation of the electrons. 
Therefore the chemical environment in the crystal and more precisely the ligand will 
affect the Ln3+ ion and will split the energy levels into several sublevels, removing their 
degeneracy. Crystal field theory (CFT) can be used to interpret the effect that a ligand can 
bring forth through bonding to the metal ion. Bonding is assumed to be electrostatic in 
nature with the ligands being the negative point charges to the positive lanthanide 
counterparts. The simplest model in CFT relies on the point charge model, which can 
qualitatively provide a measure of the crystal field splitting.  The predicted extent of the 
splitting is dependent on the approximations used for the calculations. For the 
lanthanides, the weak crystal field approximation generally suffices as the crystal field 
potential is smaller in comparison to spin-orbit interactions as the 4f orbitals are 
efficiently screened by the 5d counterparts. While it is generally accepted that the 
spectroscopy and optical properties of the lanthanides are not greatly affected by the 
surrounding ligands, crystal field splitting of the energy levels is still observed. In fact, 
the majority of the energy levels in Figure 2.1 are comprised of several split states, due to 
the spin orbit coupling, and are further split due to the crystal field effect. Maximum 
splitting occurs according to the rule 2J+1 for integer J and J+1/2 for half integers J 
(integer or half integer values of J are related to the number of unpaired electrons). An 
example of the splitting of the levels for the Er3+ ion is shown in Figure 2.2. In this case, 




Figure 2.2. Energy level splitting in the Er3+ ion where H0, Hee, HSO and HC represent the 
central field, coulombic interactions, spin-orbit coupling and crystal field Hamiltonians, 
respectively [44] (used with permission: F. Vetrone, Ph. D. Thesis, Concordia University 
(2005)). 
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2.1.3 The Selection Rules 
 
 The probability of occurrence of spectral transitions between the various energy 
levels of the lanthanide ions, shown in Figure 2.1, are governed by a set of rules known 
as the selection rules. These selection rules are developed based on the S, L and J 
parameters. There are two types of electronic transitions that are allowed, namely 
magnetic and forced electric dipole transitions. The oscillator strength of the magnetic 
dipole transitions are significantly weaker than those of their electronic dipole 
counterparts; however, they do play a significant role for 4f-4f transitions [45, 46]. The S, 
L and J selection rules for the magnetic and electric dipole transitions are summarized 
below in Table 2.2. 
 
Table 2.2. S, L and J selection rules for the magnetic and electric dipole transitions. 
Transition Type S, L and J selection rules 
  
Electric Dipole ∆S = 0; |∆L| ≤ 1; J = 0 ↔ J' = 0 and L = 0 ↔ L' = 0 are 
forbidden 
  
Forced (Induced) Electric 
Dipole 
∆S = 0; |∆L| ≤ 6; if L = 0 or L' = 0, |∆L| = 2, 4, 6; |∆J| ≤ 6; 
if J = 0 or J' = 0, |∆J| = 2, 4, 6. This implies that J = 0 ↔ 
J' = 0 and L = 0 ↔ L' = 0 are forbidden 
  




These rules are used to explain the occurrence of certain transitions between the different 
lanthanide ion states. It is important to highlight that electric dipole transitions are 
forbidden as there is no change in parity between the initial and final states [47]. 
However, due to the crystal field effect, forced (induced) electric dipole transitions may 
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occur and are of great importance as they occur in non-centrosymmetric systems where 
parity is no longer existent between the initial and final states. In this case, it is said that 
some d-orbital character is mixed with the f-orbital counterpart [45, 48]. This mixing of 
character is said to be due to the crystal field effect. Lastly, magnetic dipole allowed 
transitions may be observed as is the case for the 4I13/2 → 4I15/2 transition of the erbium 
ion.  
 
2.2 Lanthanide Luminescence and Upconversion 
 Conventionally, lanthanide luminescence, in both micron and nano-sized 
materials, is observed upon direct excitation into an excited state followed by emission 
and return of the excited ion to its ground state. A suitable excitation source such as a 
laser, of a wavelength resonant with the energy gap separating the ground and excited 
states, is required. High energy light emanating from the excitation source (UV or visible 
for example) is therefore converted to UV, visible, NIR or IR light, light of lower energy 
than the source. This process is shown for the erbium ion in Figure 2.3. A 488 nm 
excitation source (an argon gas laser for example) is used to excite the erbium ion and 
promote it to the 4F7/2 excited state after which, a non-radiative decay to the lower lying 
2H11/2 and 4S3/2 energy states occurs and is followed by green emission upon relaxation of 
the ion to the ground state. This non-radiative decay is mediated by phonons (lattice 
vibrations) discussed in detail in section 2.4 (vide infra). A second possibility involves 
further non-radiative decay to the lower lying 4F9/2 state resulting in red visible emission. 
Additional non-radiative decay pathways may result in the population of the 4I11/2 and 




Figure 2.3. Erbium ion emission following direct excitation into the 4F7/2 energy level 
(single photon absorption) using an excitation wavelength of 488 nm. 
 
 An alternative method to achieve lanthanide emission is through a process known 
as upconversion. In its simplest definition, upconversion is a process where low energy 
light such as NIR is converted to higher energy light such as UV, visible or even NIR 
(with a wavelength shorter than the excitation source). Hence, following excitation, a 
system relaxes via the emission of photons of higher energy than those absorbed through 
the excitation process [49-53]. It is a multiphoton process involving at least 2 photons. 
Unlike other multi-photon processes, absorption of the photons is sequential and not 
simultaneous. One of the most important requirements is the presence of a metastable 
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absorbing state, located between the ground and emitting states, that acts as a population 
reservoir [49]. 
 Upconversion offers an interesting alternative to conventional direct excitation for 
a myriad of reasons. Firstly, upconversion luminescence may be achieved using highly 
compact, commercially available and cheap semiconductor diodes. In fact, in some cases, 
upconversion may be observed using sub 20 mW powered diodes similar to those found 
in laser pointing devices. Secondly, in order to achieve upconversion, a NIR source is 
typically used. The use of NIR light to generate emission spanning the UV-NIR region of 
the electromagnetic spectrum is of great interest and importance as it opens up novel 
avenues in multiple research areas. One such area is in the field of display devices where 
upconverting nanophosphors can be used to replace their conventional micron-sized 
counterparts. The requirement for compact diode sources for excitation brings forth the 
advantage of miniaturization of the technology rendering displays thinner and lighter 
resulting in a significant reduction of materials required for manufacturing. It can also 
potentially render the research and development, production and recycling/recovery 
processes more "green" and ecologically-oriented. 
 There are three major mechanisms by which upconversion may occur namely 
excited state absorption, energy transfer upconversion and photon avalanche 
upconversion. The latter was not observed in the work reported in this thesis and is 





2.2.1 Excited State Absorption (ESA) 
 
 Excited state absorption involves the sequential absorption of two or more 
photons promoting an ion from the ground to an excited state [49, 54]. This process 
results in upconversion following the radiative relaxation of the ion back to its ground 
state. In Figure 2.4, ion X is in its ground state. An incoming pump photon of a 
wavelength resonant with the energy gap separating ground state G and excited state E1 
will promote the ion to this excited state (step ). A second incoming pump photon 
promotes the ion to a higher excited state, E2 (step ), followed by emission (green for 
example) and relaxation of the ion to its ground state. Assuming the energy gap 
separating G → E1 and E1 → E2 are equal, the same pump wavelength may be used 
otherwise multi-pumping sources are required. In this case, there may be requirements to  
 
 
Figure 2.4. A general mechanism for excited state absorption upconversion. 
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mitigate certain issues pertaining to beam alignment and differing pump efficiency. 
Excited state absorption is not concentration dependant and hence in low-dopant ion 
concentration systems, ESA is likely the operative mechanism for the observed 
upconversion luminescence. 
 
2.2.2 Energy Transfer Upconversion (ETU) 
 
 Energy transfer upconversion occurs via the transfer of energy between a 
neighbouring pair of ions where one ion acts as a donor of energy, while the second acts 
as an acceptor of energy. The donor ion concentration usually ranges from 10-50X that of 
the acceptor concentration. This upconversion process requires only a single pump 
wavelength and hence alignment and pump efficiency issues are not relevant. The 
existence of a metastable state is very important in ETU processes as the intermediate 
energy levels act as population reservoirs. A simplified mechanism of energy transfer 
upconversion is summarized in Figure 2.5.  In this upconversion process, an incoming 
pump photon, corresponding to the energy gap separating states G and E1, promotes both 
donor ions Y (usually an ion with a high absorption cross-section) to the intermediate 
excited state E1 (step ). In the second step (), a non-radiative energy transfer from the 
donor ion Y  to the acceptor ion X results in the promotion of the latter to its excited state 
E1 after which a second energy transfer promotes the acceptor ion to excited state E2 (). 
Following the energy transfer, the donor ions relax to their ground state while the 
acceptor ion, now in E2, undergoes a radiative decay with emission and returns to its 
ground state. The ETU mechanism is dependent on the overall dopant ion concentration 
due to the increased proximity of neighbouring ion pairs that facilitate the energy transfer 
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process. Furthermore, the mechanism efficiency is also influenced by the choice of donor 




Figure 2.5. A general mechanism for energy transfer upconversion. 
 
2.3 Erbium, Thulium and Ytterbium - A Trifecta of Luminescence 
 The tripositive erbium and thulium ions (Er3+, Tm3+) are among the most efficient 
upconverting lanthanide ions owing this to their ladder-like energy level structure and 
making them amenable to exhibit strong upconversion luminescence. This is particularly 
true when either ion (Tm3+ or Er3+) is co-doped with the tripositive ytterbium ion (Yb3+), 




2.3.1 The Erbium Ion 
 
 The strong upconversion emission of Er3+ is centered around the green and red 
regions of the spectrum. The observed green and red emissions emanate from the 2H11/2, 
4S3/2 → 4I15/2 and 4F9/2 → 4I15/2 transitions, respectively. The efficiency of the erbium ion 
upconversion emission stems from a multitude of factors. Firstly, its 4I11/2 energy level is 
resonant with the 2F5/2 level of ytterbium resulting in a very efficient energy transfer 
process (Figure 2.6). Secondly, the lifetime of the 4I11/2 → 4I15/2 transition is sufficiently 
long (~ 1 ms) to allow for the filling of the population reservoir where its electrons will 
participate in the upconversion process following the energy transfer process from Yb3+. 
  
    
Figure 2.6. Energy levels of the Er3+ and Yb3+ ions that participate in the ETU 

































Lastly, the 4F7/2 excited state of Er3+ is also resonant with the energy transferred from the 
ytterbium ion (~10,000 cm-1) in a second energy transfer process. The erbium ion is 
therefore easily excited into this energy level and multiple emissions follow as shown 
above in Figure 2.3. The erbium ion's intense visible upconversion luminescence renders 
it ideal for in vitro and in vivo imaging and assays, as well as the donor in fluorescence 
resonance energy transfer (FRET)-based applications [25, 34, 55-88]. 
 
2.3.2 The Thulium Ion 
 
 Thulium is another lanthanide ion capable of intense upconversion emission. 
Unlike erbium, thulium's major characteristic emissions are centered around the UV, blue 
and NIR regions of the spectrum. Based on the energy level diagrams of Tm3+ and Yb3+, 
it is apparent that the energy levels are not resonant (Figure 2.7). In fact the energy gap 
separating the 3H5 level of Tm3+ and 2F5/2 level of Yb3+ is ~2000 cm-1. It is however 
important to note that the crystal field splits this 3H5 level into 2J+1 states, meaning a 
maximum of 11 states. Furthermore, the 2F5/2 energy level of Yb3+ is further split 
according to the J+1/2 rule into a maximum of 3 states. Hence the energy gap separating 
the two energy levels of Tm3+ and Yb3+ is significantly less than 2000 cm-1. Following 
the energy transfer from Yb3+ to Tm3+, any additional mismatch between the two energy 
levels is dissipated as lattice vibrations. Successive energy transfers to resonant levels 
allow for the Tm3+ upconversion process to occur. The thulium ion's unique upconversion 
luminescence, which spans the UV to NIR regions renders it ideal for a multitude of 
applications. For example, UV emission following NIR excitation can be used in FRET 
applications to sensitize a photodynamic drug in cancer therapy. This would result in the 
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ability to carry out photodynamic therapy subcutaneously in deep tissue systems and not 
restrict it to surface carcinomas. Also, strong NIR emission has significant advantages 
over visible emission. Since near infrared light is more penetrating in tissue systems, NIR 
emission is expected to scatter less than visible emission and would be more easily 
detected, rendering it a valuable tool in biological assays and imaging applications [34, 




Figure 2.7. Energy levels of the Tm3+ and Yb3+ ions that participate in the ETU 
upconversion process. Resonant energy levels are shown in the same colour. Only the 3F3 
































2.3.4 The Ytterbium Ion 
 
 The effect of co-doping with ytterbium and its impact on the enhancement of the 
upconversion in lanthanide-doped systems has been widely studied. This effect has been 
observed in bulk systems such as glasses and crystals (including single crystals and 
powders) as well as in the nano domain [28, 96-118]. The Yb3+ ion possesses a 
significantly greater absorption cross-section than many of the other lanthanides with 
similar energies resulting in more efficient energy transfer processes to neighbouring ions 
(such as Er3+ and Tm3+) [53]. Furthermore, the Yb3+ ion possesses only one excited state 
resonant with the 980 nm excitation wavelength, which offers two main advantages. 
Firstly, ESA will not be possible and hence ETU will be favored and secondly, it allows 
for excitation using inexpensive commercially available diodes. Lastly as the excited 
state of Yb3+ is separated from its ground state by ~10000 cm-1, it is less prone to non-
radiative decay due to high energy phonons in some host lattices. 
 
2.4 Phonon Energy 
 The term "phonon" refers to the collective oscillation of a lattice, at the same 
frequency, generating a vibration motion. The vibration energy lost or gained in discrete 
packets is referred to as phonon energy [119]. Phonons are non-radiative, hence they do 
not contribute to the emission of the sample. Depopulation of an excited state may occur 
either via a direct transition to a lower lying state, which is radiative, or via a 
phonon-assisted transition, which is non-radiative (also referred to as non-radiative 
decay) [39]. In the latter case, the energy is taken up by the crystal as phonon energy. The 
phonon energies are therefore said to mediate the transitions from excited to lower lying 
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states. In extreme cases, lattice phonon energy can result in successive non-radiative 
decay mechanisms leading the ion to return to its ground state; however, careful selection 
of the crystal lattice can minimize such effects. It is possible to exploit lattice phonon 
energies to tailor the emissive properties of a luminescent ion selectively favouring 
emission from specific states to lower lying ones. In Figure 2.8, ion X has been doped in 
a host. If the host possesses low phonon energies (~600 cm-1), then excitation from the 
ground state to the highest excited state leads to two possibilities. In the first case, direct 
radiative emission from the excited to the ground state occurs resulting in green 
luminescence. In the second case, non-radiative decay to the lower lying intermediate 
level occurs leading to red emission. It is important to note that in this example, the gap 
separating the highest excited and intermediate states is ~5000 cm-1, hence bridging the 
gap, using phonon energies of ~600 cm-1, is not very favorable due to the requirement for 
the availability of a large number of phonons. Green emission will be dominant while 
some red emission will be observed, albeit weak, as the transition probability is low. If 
the ion is doped in a host possessing high phonon energies (~1200 cm-1), bridging the 
energy gap between the highest and intermediate excited states is likely to occur with 
greater probability resulting in a favoring of a non-radiative pathway. In this case, the red 
emission emanating from the intermediate excited state will occur with greater 
probability while a weaker green emission will be observed. By varying the host matrix, 
the luminescent properties of the probe ion may differ. This may have some advantages in 





Figure 2.8. The effect of lattice phonon energy on the luminescent properties of an ion. 
 
2.5 The Fluoride Hosts  
 
 In section 2.4, the potential impact of phonon energy on the luminescent 
properties of the lanthanides was underscored. Hence the selection of the host is critical 
in obtaining intense and efficient upconversion luminescence. Several hosts such as the 
oxides and phosphates for example have been studied for use in upconversion; however 
the associated phonon energies were quite high (usually >500-1000 cm-1) [34] resulting 


















pathways. It is in this regards that there has been a strong emphasis on fluoride based 
materials in upconversion [23, 25, 29, 30, 32, 34, 55, 68, 69, 72, 76, 80, 88, 92, 93]. The 
phonon energy of fluoride hosts such as NaYF4 or NaGdF4 has been reported to be ~ 350 
cm-1 [120] rendering them ideal hosts for upconversion processes. The efficiency of the 
upconversion process and ultimately the luminescence intensity are of greater importance 
once the nanoparticles are constituted as aqueous colloidal dispersions. In this form, the 
high-energy phonons of water or other aqueous based media (buffer or saline solutions, 
etc.) can have a detrimental effect on the upconversion luminescence. These high-energy 
phonons will ultimately result in the favoring of non-radiative pathways and the loss of 
emission intensity. Hence it is of great importance to select a system that favors an 
efficient upconversion process in order to mitigate the loss of luminescence intensity in 
aqueous media.  
 Sodium yttrium and sodium gadolinium fluoride (NaLnF4 where Ln = Y or Gd) 
are among the most efficient upconverting fluoride nanoparticle hosts. Both hosts are 
known to crystallize in either the cubic or hexagonal phases (Figure 2.9) with the 
hexagonal phase being more thermodynamically stable [121-123]. Transition from the 
cubic to the hexagonal phase may be achieved via careful manipulation of the reaction 
parameters such as synthesis temperature or reaction time. In some synthetic routes (such 
as thermal decomposition), which require addition of a precursor solution to the reaction 
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Figure 2.9. The unit cell representation for (a) cubic phase NaY(Gd)F4 and (b) hexagonal 
phase NaY(Gd)F4 (image adapted from [34]). 
Ln3+, Na+
F-
Na+ (1) F-Ln3+, Na+ (2)
35 
 
vessel, the rate of precursor addition may also play a role. In fact, the presence of a 
capping ligand on the nanoparticle surface has also been known to modulate the physical 
properties of the nanoparticles [122]. 
 The cubic and hexagonal phases of nano-sized NaY(Gd)F4 possess different 
luminescent properties. For example, NIR excitation of the cubic phase of an Er3+-doped 
host results in a more intense red emission component of the upconversion spectrum 
[124]. The opposite is true for the hexagonal phase where the green emission dominates 
the upconversion spectrum. The observed differences may arise from the differences in 
the site symmetry of the lanthanide ions, which can translate to a relaxation of the 
selection rules resulting in the observed upconversion luminescence. In addition, the 
upconversion emission intensity of the ions in the hexagonal phase has been reported to 
be at least one order of magnitude greater than that of the cubic phase [123]. This can be 
explained through the shorter Ln3+-Ln3+ distances in the hexagonal phase (~363 pm) in 
comparison to its cubic counterpart (~383 pm) leading to a greater probability of energy 
transfer over the shorter ion-ion separation distance [125].  
 Aside from their luminescent properties, another interesting aspect of the fluoride 
nanoparticle hosts is their low cytotoxic profile. Recent cells studies carried out using the 
fluorides have shown that significantly low cytotoxicity was observed even when 
administering several folds above the dosing regimen for a typical imaging experiment 
[23, 55, 63, 88, 126]. Certainly these studies do not reflect long-term safety and 





2.6 Magnetic Resonance Imaging 
2.6.1 Magnetism, Proton Spin and Frequency in Magnetic Resonance Imaging 
 
 Magnetic resonance imaging (MRI) is a medical technique that is used to image 
bodily organs and tissues by measuring the hydrogen proton spin relaxation time 
following an external radiofrequency (RF) stimulus. As tissue is comprised of primarily 
fat and water, both containing an abundance of hydrogen atoms, proton spin abundance 
can be used for imaging. Magnetic resonance imaging is a non-invasive technique 
considering that the hydrogen protons of the specimen are responsible for generating the 
detected signal. This is unlike conventional imaging techniques such as X-rays, positron 
emission tomography or echocardiography where the external source generates the 
signal. This technique provides an image, which describes the chemical environment of 
the protons throughout a slice of tissue (several mm in thickness). 
 The basic concept of MRI involves the interaction of the hydrogen proton spins 
with an applied external magnetic field. Under normal conditions, in the absence of an 
external magnetic field, protons precess about their own axis and each proton possesses 
its own magnetic field; however, the individual magnetic fields of the protons are 







Figure 2.10. Individual magnetic dipole moments of the proton spins in the absence of an 
external field. 
 
 Upon application of an external magnetic field B0, in the direction of the z-axis, 
the proton spins will align in one of two configurations: parallel or anti-parallel to the 
applied field. Initially, the number of proton spins in the parallel versus anti-parallel 
alignment is equal; however, over time, more proton spins will align in the parallel 





Figure 2.11. Alignment configuration of the proton spins with respect to the applied 





 While the proton nuclei spin about their own axes, they also commence to precess 
about the applied magnetic field. This precession also sometimes referred to as 
"wobbling" about the applied magnetic field is demonstrated in Figure 2.12. The protons 
will precess at a frequency known as the Larmor frequency. The Larmor frequency, 𝜔0, is 
usually expressed in the form of an equation known as the Larmor equation (Equation 
2.8). 
𝜔0 =  𝐵0𝛾          (Equation 2.8) 
 
where 𝛾 is the gyromagnetic ratio (a constant specific to each type of nucleus with units 
of MHz T-1). The value of the Larmor frequency, 𝜔0 (in MHz), is therefore directly 
proportional to the applied magnetic field (B0) [128, 129]. It is important to underline that 
the protons precess about the applied magnetic field, while being out of phase with one 
another.  
 




 Upon application of an RF pulse at a direction perpendicular to the applied 
magnetic field, several changes occur. This RF pulse consists of both an electric and 
magnetic component. The latter results in the generation of a much weaker magnetic 
field, B1. Once the RF is applied, the proton spins will have the tendency to commence 
precessing about B1 as well as B0. This results in a spiral motion of the net magnetization 
vector from the z-axis into the x-y plane in a process known as nutation, and the spins 
begin to precess in the transverse plane (x,y plane) perpendicular to the B0 magnetic field 
i.e. at 90° (Figure 2.13) [128]. The new precessional frequency, 𝜔1, may be expressed 
according to Equation 2.9. 
𝜔1 =  𝐵1𝛾          (Equation 2.9) 
 
 
Figure 2.13. Net magnetization vector (purple arrow) tipping as a result of the 
application of a radiofrequency pulse, with a magnetic field component (B1), in a 









Moreover, if the frequency of the RF pulse is equal to the frequency of precession of the 
protons (42.6 MHz T-1), then resonance occurs and the protons will precess in phase 
about the x,y plane. Resonance is due to the absorption of photons from the RF pulse 
resulting in a transition from the low energy to the high energy state. It is essential that 
the energy absorbed matches the energy gap separating the low and high energy states.  
 The RF pulse is applied for a short duration (1 ms) after which it is switched off. 
In the absence of the magnetic field generated by the RF wave, two processes pertaining 
to the relaxation of the proton spins and their return to equilibrium are known to occur. In 
the first process, the proton spins begin to re-align with B0 and precess along the 
longitudinal or z-axis. This occurs in an exponential fashion over time until an 
equilibrium has been reached [127]. This process is referred to as the longitudinal 
relaxation time or T1 relaxation. This recovery of the magnetization along B0 as a 
function of time is shown in Figure 2.14. The T1 relaxation time may be expressed 
according to Equation 2.10.  
 
 







𝑀𝑧(𝑡) = 𝑀0(1 − 𝑒− 𝑡𝑇1)          (Equation 2.10) 
 
where 𝑀𝑧(𝑡) is the magnetization recovery as a function of time, 𝑀0 is the magnetization 
along the longitudinal axis, which flipped due to the RF pulse and T1 is the relaxation 
time. As the proton spins recover and re-align with B0, excess energy absorbed during the 
RF pulse stimulus is released to the lattice and hence T1 is referred to as a spin-lattice 
relaxation process.  
 The second process is the decay of the magnetization along the x,y plane also 
known as the transverse magnetization or T2 relaxation (Figure 2.15). Like the 
longitudinal relaxation, this is a time dependent process; however, it is important to 
highlight that it occurs independently of the aforementioned T1 relaxation process. 
 
 









The decay of the transverse magnetization as a function of time is expressed as follows, 
 
𝑀𝑥,𝑦(𝑡) = 𝑀0𝑒− 𝑡𝑇2          (Equation 2.11) 
 
where 𝑀𝑥,𝑦(𝑡) is the transverse magnetization and T2 is the relaxation time. The T2 
relaxation process does not occur at the same rate as the exponential growth of T1 
(Equation 2.10). In fact, decay of the transverse magnetization occurs ~5-10X faster than 
the T1 recovery [127]. This is due to two principal reasons namely spin de-phasing and 
magnetic field inhomogeneity. Spin de-phasing is caused by proton-proton interactions. 
The individual magnetic moment of a proton spin impacts its neighbour. Furthermore as 
some proton spins are aligned in either the parallel or anti-parallel states, this can further 
impact the magnitude of the spin de-phasing. Proton spins, which begin to re-align with 
the longitudinal magnetic field may therefore experience a different effect relative to 
spins which have yet to re-align. This effect is caused by both B0 and the individual 
magnetic moment of a neighbouring proton spin (in an opposite alignment state). 
Magnetic field inhomogeneity will also play a role in spin de-phasing. Under normal 
experimental conditions, the magnetic field is not ideal and hence small inhomogeneities 
will further contribute to spin-dephasing. A coil aligned perpendicular to the magnetic 
field measures the decay of the amplitude (free induction decay) of the magnetization 







2.6.2 From an Electromagnetic Wave Signal to an Image 
 
 The pulse sequence may be designed to sample greater contrast differences in T1 
versus T2 and is said in that case to be T1-weighted. Alternatively, pulse sequencesthat 
are designed to sample greater contrast differences in T2 are referred to as T2-weighted 
[130]. Aside of the applied static magnetic field, a much weaker gradient magnetic field 
(~1/1000) is applied throughout different positions of the scanned specimen. This 
variation in the magnetic field ultimately results in the protons precessing at different 
frequencies. This difference means that the proton spins will be at different positions 
along the precessional path and this can be translated into a term known as the  phase of 
the magnetic moment. Switching off the gradient will result in the re-phasing of the 
proton spins. This variation is detected in the x, y and z axes and used to obtain 
information regarding the position in the specimen where these signals have been 
generated [130, 131]. The electromagnetic wave signal observed as the response from the 
specimen during MRI analysis does not provide any direct information that can be 
translated to a conventional MRI image. The signals acquired are referred to as an echo 
and each echo differs from the other as it is characterized by the radiofrequency pulse 
used and the magnetic gradient applied. The signal is converted to a digital form using an 
analog-to-digital converter to form what is known as the k-space (a signal in the x and y 
axes) [131]. This conversion then requires a Fourier transform treatment, which 
transforms the observed signal into a weighted sum of position-dependent grey-scale 





Figure 2.16. Fourier transformation of the k-space signal to an MRI image. Following 
the mathematical treatment, an MRI image of a human brain is revealed (Image adapted 
from [131]) (used with permission from IOPScience). 
 
2.6.3 The Role of Contrast Agents in MRI 
 
 Increasing the signal intensity and enhancing the image contrast translates to 
improving the MRI image. This is a concern in the effort to reach low-detection levels 
when using MRI as a diagnostic tool. The proton density in a given specimen cannot be 
modified. For example, the number of hydrogen protons in a tissue sample cannot be 
increased to enhance the MRI signal. Hence, other approaches are required for signal 
enhancement to occur. While there exists an opportunity to enhance the signal through 
instrumental design (magnet or coil) or through experimental control (pulse frequency 
variation for example), the most efficacious way is through the modulation of the T1 and 
T2 relaxation times of the hydrogen protons located in the specimen of interest [132]. 
This can be carried out using contrast agents (CAs) containing paramagnetic species. 




relaxation properties resulting in an enhancement effect.  
 Depending on the how the proton relaxation process is altered, CAs are usually 
classified as T1 or T2 agents. Certain CAs are used for T1 modulation, most notably 
gadolinium-based complexes. In contrast, iron oxide nanoparticles are strictly used as T2 
agents. It is important to highlight that shortening of either the T1 or T2 relaxation times 
cannot be carried out non-discriminately and requires a certain measure of balance. 
Shortening the T1 relaxation times, through the use of the optimal concentration of a 
contrast agent, will enhance the signal intensity; however, in excess CA concentration, 
the signal intensity will be negatively impacted [132, 133].  
 The concept of the shortening of the relaxation times is more appropriately 
expressed as the relaxation rate, also known as the relaxivity. The relaxivity describes the 
proton relaxation rate and is expressed as the observed relaxation rate, 1/Ti,obs where the 
subscript i has values of 1 and 2 (for T1 and T2) [134-137]. The observed relaxation rate 
may be expressed as follows, 
 1
𝑇𝑖,𝑜𝑏𝑠� =  1 𝑇𝑖,𝑑� + 1 𝑇𝑖,𝑝�           (Equation 2.9) 
 
where 1/Ti,d and 1/Ti,p represent the sum of the diamagnetic (d) and paramagnetic (p) 
terms of the solvent nuclei relaxation rate in the absence and presence of the contrast 
agent, respectively. The paramagnetic term in Equation 2.9 above is dependent on the 
concentration of the contrast agent and can be re-written as follows, 
 1




where [𝐶𝐴]  is the contrast agent concentration. In sufficient CA concentrations, an 
enhancement effect can be observed. This effect arises from dipole-dipole interactions 
between the solvent-proton spin and the fluctuating magnetic field due to the unpaired 
electrons of the paramagnetic agent. The paramagnetic agent-proton nuclei interactions 
may occur through the inner sphere contribution (chemical exchange from the bulk). 
Alternatively, solvent molecules surrounding the paramagnetic metal ion, in the outer 
sphere, also experience an enhancement due to random translational effects [134] (Figure 
2.17). Surface ligands coordinating the metal ion in a complex, or capping an inorganic 
nanoparticle may also result in an additional enhancement effect if they are capable of 
hydrogen bonding. For example, carboxylate and phosphate groups have been reported to 
have this additional enhancement effect in what is known as a second sphere relaxation 
mechanism [138]. The overall enhancement is lower than that observed for the inner 
sphere but could play a role in designing an MRI contrast agent. 
 Gadolinium-based chelated complexes have been predominantly used for contrast 
enhancement especially for T1 imaging. Gadolinium is the most paramagnetic ion in the 
periodic table with seven unpaired electrons offering strong interactions with the proton 
spins. It is present in complexes in the Gd3+ ionic form. As it possesses nine coordination 
sites, the gadolinium ion is chelated to 8 atoms in the complex to enhance its stability 
with the last coordination site reserved for interaction with water protons. One area of 
concern regarding gadolinium-based contrast agent complexes has been the leaching of 
free Gd3+ ions from the complex and into the body resulting in significant toxicity [139, 
140]. Hence, significant efforts have targeted inorganic-based nanoparticles as a suitable 
alternative. Current studies have shown that Gd3+-based inorganic nanoparticles may be 
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used to achieve T1 and T2 contrast enhancement; however no body of work has been 
carried out regarding the optimization of the gadolinium concentration levels in order to 
achieve the optimum signal enhancement [141-153]. In addition to Gd3+ concentrations, 
the particle size is of great importance when considering enhancement effects. The 
increase in surface area to volume ratio upon decrease of the particle size will result in a 
higher Gd3+ ion density at the surface and consequently a greater enhancement effect 
should be observed.  
 
 
Figure 2.17. Interaction of the electron spin of a paramagnetic ion with solvent (water) 
protons (Image adapted from [134]). The terms kexchange and τR refer to the metal 
ion/water exchange and particle tumbling rate, respectively. The inner hydration sphere is 







Chapter 3    - Experimental Procedures For Synthesis and Surface 
Modifications 
3.1 Synthesis Procedures for the Preparation of Lanthanide-Doped Nanoparticles 
3.1.1 The Thermal Decomposition Synthesis 
 
 The thermal decomposition synthesis is comprised of a two-step process where 
the lanthanide trifluoroacetate precursors are prepared in the first step, followed by the 
decomposition of the precursors, and the formation of ligand-capped NaY(Gd)F4:Er3+ (or 
Tm3+), Yb3+  nanoparticles in the second step. 
 
3.1.1.1 Procedure for the Synthesis of Gd3+, Tm3+, Yb3+ Trifluoroacetate Precursors 
 
 The precursors to NaGdF4 co-doped with Tm3+ and Yb3+ were prepared via 
addition of a 10 mL mixture of water/trifluoroacetic acid (1:1) to a round bottom flask 
containing 6.25 x 10-6 mol of Tm2O3 (0.0024 g, 0.5 mol% Tm3+), 3.13 x 10-4 mol of 
Yb2O3 (0.1232 g, 25 mol% Yb3+) and 9.31 x 10-4 mol of Gd2O3 (0.3354 g, 74.5 mol%). 
The cloudy solution was refluxed at 80 ºC in excess of 12 h until it was clear. The 
solution was then heated to dryness, on a hotplate, at 60 ºC for several hours to evaporate 
the water/trifluoroacetic acid.  
 
3.1.1.2 Procedure for the Synthesis of the Gd3+, Er3+, Yb3+ Trifluoroacetate 
Precursors 
 
 The precursors to NaGdF4 co-doped with Er3+ and Yb3+ were prepared in an 
identical manner to the precursors in section 3.1.1.1; however, 5.00 x 10-5 mol of Er2O3 
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(0.0096 g, 2.0 mol% Er3+), 5.00 x 10-4 mol of Yb2O3 (0.0985 g, 20 mol% Yb3+) and 1.95 
x 10-3 mol of Gd2O3 (0.3534 g, 78.0 mol%) were added to the water/trifluoroacetic acid 
solution and allowed to reflux at 80 ºC in excess of 12 h until it was clear. The solution 
was then heated to dryness, on a hotplate, at 60 ºC for several hours to evaporate the 
water/trifluoroacetic acid.  
 
3.1.1.3 Procedure for the Synthesis of the Y3+, Tm3+, Gd3+, Yb3+ Trifluoroacetate 
Precursors 
 
 The precursors to NaYF4 tri-doped with Tm3+, Gd3+ and Yb3+, used for MRI 
studies, were prepared following the same approach reported in section 3.1.1.1; however 
Gd2O3 was used to substitute for yttrium in concentrations ranging from 0-74.5 mol%. 
Table 3.1 summarizes the experimental quantities used for the tri-doped system as a 
function of Gd2O3 concentration. 
 
Table 3.1. Synthesis of precursors of NaYF4 tri-doped with Tm3+, Gd3+ and Yb3+. 
Amounts shown are in grams and reflect the quantities of material needed to prepare the 















Y2O3 0.2103 0.2075 0.2032 0.1962 0.0000 
Tm2O3 0.0024 0.0024 0.0024 0.0024 0.0024 
Yb2O3 0.1232 0.1232 0.1232 0.1232 0.1232 
Gd2O3 0.0000 0.0045 0.0113 0.0227 0.3376 
 
 
3.1.2 Procedure for the Synthesis of Lanthanide-Doped Upconverting Nanoparticles 
 
 In the second step of the synthetic procedure, 12.5 mL of oleic acid and 12.5 mL 
of 1-octadecene were added to a 3-neck round bottom flask (solution A). A sample of 
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2.50 x 10-3 mol of CF3COONa (0.3400 g) was added to the dried precursor solids 
(Sections 3.1.1.1-3.1.1.3) along with 7.5 mL of oleic acid and 7.5 mL of 1-octadecene 
(solution B). Both solutions were degassed at 150 ºC for 30 min under vacuum to remove 
any moisture present. Subsequently, solution A was heated to 310 ºC and was held at that 
temperature for several minutes under a gentle flow of argon. Addition of solution B to 
solution A was carried out using a syringe and pump system at a rate of 1.5 mL/min 
(Harvard Apparatus Econoflow). After 10 min, the addition of solution B was completed 
and the system temperature was maintained at 310 ºC under vigorous stirring for 60 min. 
The solution was allowed to cool to room temperature. Nanoparticles were precipitated 
out using ethanol (99%) and were isolated via centrifugation at 4000 rpm (corresponding 
to a relative centrifugal field of 1350) for 15 min. The solids were washed with a 1:6 
hexane/ethanol (99%) mixture twice to remove any impurities. A yield of 80-85% was 
typically obtained. 
 
3.1.3 Procedure for the Variation of The Synthetic Parameters of The Thermal 
Decomposition Synthesis 
 
 A study was carried out to optimize the thermal decomposition synthetic 
parameters namely, reaction temperature, precursor rate of addition and reaction time. 
Precursors of NaGdF4 co-doped with Er3+ and Yb3+ were prepared according to the 
method outlined in section 3.1.1.2. A summary of the conditions used for the synthesis is 





Table 3.2. Variation of the thermal decomposition reaction parameters.  
 
Reaction                 
Temperature (°C) 
Precursor Addition Rate 
(mL/min) 
Reaction                         
Time (min) 
280, 290, 300, 310, 320, 330 1.5 60 
310 0.5, 1.0, 1.5, 2.0, 2.5 60 




3.1.3 Procedure for the Synthesis of NaGdF4:Tm3+/Yb3+ Ultra Small Nanoparticles 
 
 To prepare ultra small nanoparticles, 0.78 mmol of GdCl3 (0.2884 g), 0.02 mmol 
of TmCl3 (0.0026 g), and 0.2 mmol of YbCl3 (0.0998 g) were added to a 100-mL flask 
containing 4 mL of oleic acid and 15 mL of 1-octadecene. The solution was heated to 150 
°C for 30 min and then cooled to room temperature. A 10 mL methanolic solution of 
NH4F (4 mmol, 0.1500 g) and NaOH (4 mmol, 0.1000 g) was slowly added to the flask 
using a syringe and pump system at a rate of 0.5 mL/min (Harvard Apparatus 
Econoflow), and the resulting solution was stirred for 24 hours. The solution was slowly 
heated to remove methanol and finally heated at 265 °C for 30 min under argon flow. 
Nanoparticles were precipitated via addition of ethanol (99%) and were collected by 
centrifugation at 4000 rpm (corresponding to a relative centrifugal field of 1350) for 15 






3.2 Water Dispersibility via Post-Synthetic Surface Modifications  
3.2.1 Procedure for the Oleate-Citrate Ligand Exchange 
 
 The ligand exchange of oleate molecules, capping the nanoparticle surface, with 
trisodium citrate was carried out by dispersing 60 mg of nanoparticles in 5 mL of hexane. 
In the next step, 5 mL of 0.2 M trisodium citrate buffer (adjusted to pH 4 using 
concentrated HCl) was added to the nanoparticle colloidal dispersion. The two-phase 
solution was setup on a shaker for 3 hours at a speed of 700 rpm. The aqueous/organic 
system was then poured into a separatory funnel and the aqueous phase, now containing 
the nanoparticles, was isolated. The nanoparticles were precipitated with acetone (1:5 
aqueous:organic ratio) and centrifuged for 15 min at 4000 rpm (corresponding to a 
relative centrifugal field of 1350). The organic solvent was discarded and the solids 
recovered were re-dispersed in 5 mL of trisodium citrate buffer (adjusted to pH 7 using 
concentrated HCl). The dispersion was placed on the shaker for an additional two hours. 
Following this, the nanoparticles were precipitated using acetone (1:5 aqueous:organic 
ratio) and isolated via centrifugation. The recovered solids were water dispersible and 
showed upconversion luminescence following NIR excitation. 
 
3.2.2 Procedure for Silica Coating of Lanthanide-Doped Nanoparticles 
 
 Hydrophobic nanoparticles were rendered dispersible in aqueous media via a 
modified Stöber process [154]. In this reverse micro-emulsion method, 25 mg of 
hydrophobic nanoparticles were added to 250 mg of Igepal CO-520 and 5 mL of 
cyclohexane, and the mixture was sonicated for 30 min to ensure a clear colloidal 
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dispersion was obtained. Following sonication, the dispersion was added to a solution of 
Igepal CO-520 (2.25g)/cyclohexane (3 mL) and the mixture was left to stir for 30 
minutes. A 100 µL aliquot of concentrated ammonium hydroxide was added to the 
mixture and it was sonicated for an additional 30 minutes. Finally, 60 µL of 
tetraethylorthosilicate (TEOS) was added and the dispersion was left to stir for at least 18 
hours. The silica-coated nanoparticles were isolated via precipitation with acetone 
followed by centrifugation and subsequent washing with a water/ethanol mixture (1:1). 
The silica-coating procedure outlined above was derived following a study carried out to 
optimize the coating procedure. A summary of the optimization study is shown below in 
Table 3.3. 
 
Table 3.3. Optimization of the silica coating procedure for lanthanide-doped 
nanoparticles. All experiments in this study were carried out using a fixed nanoparticle 
weight (25 mg).  
Amount of Igepal CO-520 
Used (g) 
Amount of TEOS Used 
(µL) 
Reaction                         
Time (hours) 
1.0, 1.5, 2.0, 2.5, 3.0 50 60 
2.5 30, 40, 50, 60, 70 60 
2.5 60 4, 8, 16, 24, 48 
 
3.3 Surface Functionalization of Silica-Coated Nanoparticles  
3.3.1 Procedure for the Surface Modification of Silica-Coated Nanoparticles 
 
 Grafting of (3-aminopropyl)trimethoxylsilane (APTMS) and/or (3-azidopropyl) 
triethoxylsilane (AzPTES) to the silica coated surface was carried out by adding 250 mg 
of silica-coated nanoparticles to a vial containing 6 mL of ethanol (99%), and the mixture 
was sonicated for 1 hour. In a separate vial, 500 µL of APTMS (or AzPTES or a 1:1 
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mixture of both) was added to a 25 mL solution comprised of water/ethanol (v/v, 
5%/95%) with an adjusted pH of ~4.5-5 (adjusted using glacial acetic acid). The 
nanoparticle dispersion was added to the silane solution and was left to stir overnight at 
room temperature. The nanoparticles were isolated via precipitation with acetone 
followed by centrifugation at 4000 rpm (corresponding to a relative centrifugal field of 
1350) for 15 minutes. The isolated nanoparticles were subsequently washed twice with a 
water/ethanol (99%) mixture (1:1).  
 
3.3.2 Procedure for the Ninhydrin Test 
 
 A quantitative ninhydrin test was carried out by first preparing an amine standard 
calibration curve. A 150 µg/mL standard solution of serine (7.5 mg in 50 mL deionized 
water) was prepared in a volumetric flask. Volumes of 0-1 mL of the amine standard were 
pipetted in glass test tubes after which 4 mL of distilled water were added. The ninhydrin 
reagent prepared at a concentration of 0.15 mg/mL (2.25g in 15 mL of acetone) was 
added in a volume of 1 mL to each test tube. The tubes were vigorously mixed, covered 
with aluminum foil, sealed with parafilm and left for 15 minutes in a water bath at 100 
°C. The test tubes were allowed to cool to room temperature in a water bath and then 1 








3.3.3 Procedure for Platinum Functionalization of Silica-Coated Lanthanide-Doped 
Nanoparticles 
 
 Nanoparticles functionalized solely with cis-platinum were prepared by adding 
50-250 µL aliquots of a 2.4x10-3 M solution (in water) of K2PtCl4 to a nanoparticle 
dispersion (amine functionalized surface) prepared in a 1:3 degassed water/methanol 
mixture (degassed for 30 minutes under an argon flow). The solution was stirred 
overnight, at room temperature. The nanoparticles were isolated via centrifugation at 
4000 rpm (corresponding to a relative centrifugal field of 1350) for 15 minutes, and were 
washed twice using a cold (5 °C) water/ethanol (99%) mixture (1:1). 
 
3.3.4 Procedure for Conversion of Folic Acid to Propargyl Folate 
 
 Approximately 0.10 g of folic acid (2.27x10-4 mol) was dissolved in 8 mL of 
DMF and 2 mL of DMSO. This was followed by the addition of NHS and EDAC in 
amounts of 1.1509 g (10x10-3 mol) and 0.6067 g (3.17 x10-3 mol), respectively. The 
mixture was left to stir for 1 h. Finally, a solution consisting of 0.350 g of propargylamine 
(6.35 x10-3 mol) in 2 mL of DMF was added drop-wise to the reaction mixture and stirred 
overnight. Acetone was used to precipitate the converted folic acid, which was isolated 
using centrifugation at 4000 rpm (corresponding to a relative centrifugal field of 1350) 
for 15 minutes. The isolated propargyl folate was washed twice with acetone and 





3.3.5 Procedure for a One-Pot One-Step Functionalization of Propargyl Folate and 
cis-Platinum to the Nanoparticle Surface 
 
 The simultaneous modification of the nanoparticle surface with propargyl folate 
and cis-platinum was carried out using a one-pot, one-step approach. Approximately 50 
mg of nanoparticles and 20 mg of propargyl folate were dispersed in a 10 mL (1:1) 
degassed water/methanol solution (degassed for 30 minutes under an argon flow) and 
were sonicated for 30 minutes. A 250 µL aliquot of an aqueous K2PtCl4 solution (2.4x10-3 
M) were added to the nanoparticle/propargyl folate dispersion along with 50 µL of 
aqueous CuSO4 (0.1 M), aqueous sodium ascorbate (0.1 M) and triethylamine. The 
mixture was left to stir overnight in the absence of light (covered with aluminium foil). 
Propargyl folate and cis-platinum decorated nanoparticles were isolated via centrifugation 
at 4000 rpm (corresponding to a relative centrifugal field of 1350) for 15 minutes, and 
washed twice using a cold (5 °C) water/ethanol (99%) mixture (1:1). The solids were 








Chapter 4 - Controlled Size, Phase and Morphology - Colloidal 
Upconverting Fluoride Nanoparticles 
4.1 Optimization of the Thermal Decomposition Synthesis - Towards Particle Size 
Control and Monodispersibility 
 
 The thermal decomposition synthesis of fluoride host nanoparticles (example 
NaGdF4 or NaYF4) requires the addition of the trifluoroacetate precursors, dissolved in a 
mixture of oleic acid and 1-octadecene, into a secondary reaction flask containing the 




Figure 4.1. Formation of oleate-capped lanthanide-doped nanoparticles following 











 Based on this previous statement, four key synthetic parameters, which may 
impact the formation of the nanoparticles, can be identified. The first parameter is the 
oleic acid capping ligand to 1-octadecence non-coordinating solvent ratio. The amount of 
capping ligand present can strongly influence the nanoparticle formation (size and phase) 
by impacting the nucleation and growth processes. This parameter was previously studied 
in the work of Mai et al. [30, 122], which showed that NaGdF4 (and NaYF4) nanoparticle 
formation and growth is sensitive to the organic phase in the reaction. Furthermore, this 
parameter was also investigated in detail by the Capobianco group, and a 1:1 oleic 
acid:1-octadecene ratio was deemed ideal for the thermal decomposition synthesis [29].  
The oleate anion caps the nanoparticle surface through an electrostatic interaction 
between its negatively charged carboxylate oxygens and the positively charged 
nanoparticle surface [155-157]. The surface positive charge of the latter is due to the 
presence of the bound lanthanide ions at the surface (Figure 4.2). The negative charge of 
the carboxylate ion is delocalized across the O-C-O bonds allowing for a bi-dentate 
anchoring point to the nanoparticle surface. This delocalization of the negative charge 
offers the most energetically favorable configuration for the oxygen atoms of the 
carboxylate ions. From Figure 4.2 below, it can be envisioned that both oxygen atoms can 
therefore interact with the lanthanide ions at the surface of the nanoparticle. The 
bi-dentate interaction between the oxygen atoms and the lanthanide ions results in the 
anchoring of the capping ligand to the nanoparticle. Thermogravimetric analysis has 
shown that the nanoparticles exhibit a 10-12% weight loss on heating from 350-450 °C 




Figure 4.2. Electrostatic bond between the negatively charged oxygen atoms and the 
positively charged lanthanide-doped nanoparticle surface [155] (used with permission 
from the American Chemical Society).   
 
 The remaining three parameters that play an important role in the fluoride 
nanoparticle formation are 1) reaction temperature, 2) reaction time and 3) precursor 
addition rate to the reaction vessel. Hence, an optimization study was designed in order to 
determine the effect of each parameter on the nanoparticle size, morphology, crystal 
phase and optical properties. Only one parameter was varied per synthesis to ensure that 
the results obtained can be directly correlated to the change that was brought forth. The 
system selected for the study was NaGdF4, which was co-doped with both Er3+ and Yb3+ 
at 2 and 20 mol%, respectively. 
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4.1.1 The Effect of the Precursor Addition Rate 
 
 The precursor addition rate to the secondary reaction vessel was the first synthetic 
parameter investigated in the study. This was carried out by varying the addition rate 
from 0.5 to 2.5 mL/min in 0.5 mL/min increments. Typically the transfer of the hot 
precursor solution containing gadolinium, erbium and ytterbium trifluoroacetates was 
carried out by first pressurizing the precursor flask with argon gas and then using a 
stainless steel syringe to cannulate the solution to the secondary reaction vessel [29, 159].  
This method however could not be easily controlled to allow for consistent and 
reproducible transfer rates from one flask to another. Hence, a mechanical syringe and 
pump system were used in lieu of cannulation to gain a measure of precision of the 
precursor addition as well as remove operator dependence [160]. The syringe and pump 
system was used for all synthetic work reported in this thesis. While the precursor 
addition rate was varied, the reaction temperature and time were maintained at 310 °C 
and 60 minutes, respectively. These conditions were selected as a starting point based on 
previous works carried out in the Capobianco research group [29, 161]. 
 Following the synthesis of the NaGdF4:Er3+/Yb3+ nanoparticles prepared at 
different precursor addition rates (0.5-2.5 mL/min), transmission electron microscopy 
(TEM) analysis was carried out to investigate the effect of varying this reaction condition 









Figure 4.3. Transmission electron microscopy digital images of NaGdF4:Er3+/Yb3+ 
upconverting nanoparticles at (a) low magnification (22,000X) and (b) high 
magnification (97,000X) as a function of the precursor injection rate (0.5-2.5 mL/min).  
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 Upon examination of the TEM images, it was observed that the colloidal 
nanoparticles self-assembled folloiwng drying of the dispersion on the copper grid. This 
self-assembly is typical of colloidal particles and results in the reduction of the free 
energy of the system [162-166]. From Figure 4.3, the particle size was observed to 
decrease as a function of increasing precursor addition rate to the reaction vessel. This is 
evident upon comparison of both low and high magnification TEM images especially for 
the nanoparticles prepared at 1.0-2.5 mL/min. At the slowest addition rate of 0.5 mL/min, 
a range of sizes spanning 8-120 nm was observed. At this condition, the particle size 
varies significantly and a discussion of the mean particle size is necessary. The mean 
particle sizes are summarized in Table 4.1. 
 
Table 4.1. Mean particle size values for NaGdF4:Er3+/Yb3+ upconverting nanoparticles 
prepared at different precursor addition rates (0.5-2.5 mL/min). 
Addition 
Rate 




32.2 ± 33.2 42.1 ± 3.1 15.4 ± 1.9 12.4 ± 1.3 9.4 ± 1.5 
 
 
While the mean particle size of the sample prepared at 0.5 mL/min appeared to be smaller 
than that of the sample prepared at the 1.0 mL/min injection rate, the calculated standard 
deviation of the measurements suggested a much higher level of polydispersity. At a 0.5 
mL/min addition rate, the calculated standard deviation was in fact greater than the 
average particle size. Upon consideration of this result, the data obtained at 0.5 mL/min 
were in accordance with the remainder of the trend observed upon increase of the 
addition rate. The decrease in the particle size with the increasing addition rate can be 
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explained through the processes of nucleation and growth. At a very slow addition rate 
such as 0.5 mL/min, the trifluoroacetate precursors are introduced in the reaction vessel 
at a very slow speed. An initial burst of nucleation will occur; however, due to the slow 
precursor addition rate, these nuclei grow while others begin to form. The nucleation and 
growth processes are competitive at this point as more precursors decompose over the 
length of the addition period (30 minutes) forming new nuclei while previously formed 
nuclei continue to grow resulting in a highly polydisperse sample. Increase of the 
addition rate to 1.0 mL/min resulted in a significant decrease of the polydispersity due to 
the availability of a sufficient precursor feed to support the growth process. Moreover, at 
this precursor addition rate, there is a greater balance between nucleation and growth, 
with the equilibrium being shifted towards the growth process. Nucleation will initially 
relieve the super saturation of the system from the decomposed materials followed by 
support of the growth of the nuclei sinks as the precursor feed is maintained. This is in 
accordance with the observed larger particle size (~ 40 nm) in comparison to what was 
noted for the remaining conditions. Further increase in the addition rate from 1.5-2.5 
mL/min resulted in the reduction of the particle size. Under these conditions, nucleation 
is favored over growth. A high concentration of decomposed precursors in the reaction 
vessel results in the initial formation of a large number of nuclei followed by growth over 
the duration of the reaction. As a greater number of nuclei were formed at 2.5 mL/min 
versus the 1.5 mL/min condition, the particle size was expected to decrease since fewer 
amounts of decomposing material would be available to contribute to the growth regime.  
 Particle size distribution analyses were carried out for the nanoparticles 
synthesized at different precursor injection rates (Figure 4.4). The narrowest distributions 
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were observed at the 1.5-2.5 mL/min injection rates while a double Gaussian fit was 
required in order to account for the polydispersity of the sample prepared at 0.5 mL/min. 
 
  
Figure 4.4. Particle size distribution of NaGdF4:Er3+/Yb3+ upconverting nanoparticles 
prepared as a function of precursor injection rate (0.5-2.5 mL/min). 
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 The nanoparticles prepared at all injection rates were crystalline, and lattice 
fringes were observed in the high magnification TEM images similar to that shown in 
Figure 4.5. For example lattice fringes corresponding to d-spacings of 0.303 and 0.523 
nm were observed and attributed to the (110) and (100) planes, respectively, of the 
hexagonal phase of NaGdF4.  
 
 
Figure 4.5. Lattice fringes observed in TEM images of NaGdF4:Er3+/Yb3+ upconverting 
nanoparticles (Magnification 380,000X). Sample shown is that prepared using 1.5 










 TEM diffraction analysis (Figure 4.6) revealed diffraction rings indicative of the 
formation of crystalline materials. The diffraction rings were indexed to either the cubic 
or hexagonal phases of NaGdF4, the two phases in which it is known to exist.  
 
 
Figure 4.6. Electron diffraction rings obtained by TEM for NaGdF4:Er3+/Yb3+ 















 From Figure 4.6, electron diffraction patterns were observed to appear as bright 
spots and concentric diffraction rings. This difference was attributed to the crystallite size 
and orientation of the nanoparticles. When the diffraction spots in the rings are 
resolvable, this implies that the diffraction pattern was taken from a small number of 
large crystallites. In the opposite case when the bright spots in rings cannot be resolved, it 
is the result of the diffraction pattern being taken from a large number of rather small 
crystallites. This may also occur due to the presence of more than one crystalline phase in 
the sample. Several differences were observed between the diffraction ring patterns of the 
samples prepared at the 0.5 and 1.0 mL/min injection rates. For example, the sample 
prepared at 0.5 mL/min showed diffraction rings ascribed to the (111), (200), (220) and 
(311) planes of the cubic phase of NaGdF4 [167]. The diffraction ring pattern obtained at 
1.0 mL/min differed significantly, indicative of the presence of a different phase, and the 
diffraction rings observed were ascribed to the (100), (110), (200), (111), (201), (210) and 
(211) planes of the hexagonal phase of NaGdF4 [168]. Samples prepared at 1.5-2.5 
mL/min did not show any indication of the presence of the cubic phase; however, it was 
not possible to ascertain the presence (or absence) of the cubic phase even in small 
concentrations based on the electron diffraction rings. Hence, in order to confirm the 
crystal phase, X-ray powder diffraction (XRD) studies were carried out and the results 
are summarized in Figure 4.7. Comparisons are drawn to the hexagonal (JCPDS 27-699) 
and cubic (JCPDS 6-0342) phase reference patterns of bulk (micron-sized) NaGdF4. The 
experimental XRD patterns were in accordance with the reference patterns of the bulk 
phase with the exception of the observed peak shifts ascribed to the doping effect. It is 
important to highlight that the samples prepared were doped with 2 and 20 mol% of Er3+ 
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and Yb3+, respectively, while the reference patterns belong to undoped NaGdF4 cubic and 
hexagonal hosts. The insertion of the ions in the host lattice following the synthesis 
results in the observed peak shifts as the lattice may become distorted due to the 
accommodation of ions with varying cationic radii. In comparison to the reference 
patterns, the experimental results for the nanoparticles synthesized show significant 
broadening. This broadening effect, attributed to a decrease of the particle size, is 
typically observed when the diffraction domain reaches a critical size  (< 0.1 µm). With 
decreasing particle size, an increase in the number of crystal defects occurs along with 
interruptions of the periodicity. As a result, broader diffraction patterns are observed. 
 At the slowest injection rate, the nanoparticles predominantly formed in the cubic 
crystal phase (marked by "c" in Figure 4.7); however, a minor hexagonal phase 
component was also observed (marked by "h"). As the injection rate was increased to 
1.5-2.5 mL/min, the nanoparticles formed predominantly in the hexagonal phase. It is 
important to highlight that the hexagonal phase results in upconversion emission ~1 order 
of magnitude greater than that of its cubic counterpart. This occurs due to the more 
efficient energy transfer between the ions (for example from Yb3+ to Er3+ or Tm3+) [121, 
169]. This is of particular importance especially considering that following ligand 
modification and/or ligand exchange as well as post synthetic modifications coupled with 
dispersion in water (discussed in Chapters 5 and 6), it is expected that the luminescence 
of the nanoparticles would decrease due to the presence of OH groups (from water or 
silica) with phonon energies of ~3500 cm-1, inevitably leading to an increase in non-
radiative pathways and diminished upconversion emission intensity. The probability of 
bridging the energy gaps therefore increases significantly. It follows that the desired 
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phase for the synthesized nanoparticles is the hexagonal phase due to the increased 
luminescence in comparison to the cubic counterpart.  
   
         
 
Figure 4.7. XRD analysis of NaGdF4:Er3+/Yb3+ upconverting nanoparticles prepared at 
different precursor injection rates (0.5-2.5 mL/min). Peaks marked with "c", "h" and "*" 
are attributed to the cubic and hexagonal phases of NaGdF4 and the hexagonal phase of 
GdF3, respectively. Peaks in the diffraction pattern of the samples prepared at 1.5-2.5 
mL/min are all attributed to the hexagonal phase. Plane assignments (top of the Figure) in 
green and brown are attributed to the hexagonal and cubic phases, respectively. 
 
 In addition to the cubic and hexagonal phases, some additional diffraction peaks 
(marked by a * in Figure 4.7) were also observed and could not be attributed to either the 
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cubic or hexagonal phases. Analysis of these peaks suggested that they are in fact due to 
the presence of a minor hexagonal GdF3 phase. This phase was present in < 5% 
throughout all the samples prepared in this study. 
 As the injection rate increased, the particle size decreased and as a result, the 
XRD peaks were observed to broaden. This effect was noticeable upon comparison of the 
0.5 and 2.5 mL/min samples. The XRD peak broadening occurred due to the decrease in 
crystallite size and hence the size of the diffracting domain. This results in the increase of 
the peak width as well as in the shifting of the reflections throughout the diffraction 
pattern [170]. The XRD patterns were further analyzed using Rietveld fitting in order to 
quantify the extent of formation of either cubic or hexagonal phase as a function of the 
reaction conditions. An example of a diffraction pattern fitting is shown in Figure 4.8a, 
while a plot of the percent cubic phase as a function of precursor injection rate is shown 
in Figure 4.8b. A decrease in the quantity of the cubic phase was observed with 
increasing precursor injection rate, which was in agreement with the XRD results shown 
above. The percent cubic phase decreased from ~82% to 8% on transition from 0.5 - 1.0 
mL/min followed by another minor decrease to a value of 5% as the injection rate was 








Figure 4.8. (a) Rietveld fitting of the XRD pattern of the NaGdF4:Er3+/Yb3+ upconverting 
nanoparticle sample prepared at 1.5 mL/min precursor injection rate and (b) the cubic 
phase content of NaGdF4:Er3+/Yb3+ nanoparticles as a function of increasing precursor 
injection rate (0.5-2.5 mL/min). 
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 The upconversion luminescence properties of the NaGdF4:Er3+/Yb3+ nanoparticles 
prepared at different precursor injection rates were evaluated (Figure 4.9). The 
nanoparticles used for the synthesis optimization studies were co-doped with tripositive 
erbium (Er3+) and ytterbium (Yb3+) as this combination of ions is known to be among the 
strongest upconverters in the visible region of the spectrum. Furthermore, the sensitivity 
of the ratio of the red:green emission of erbium to the crystalline phase allows for the use 
of this ion combination as a probe to investigate the effect that the reaction parameters 




Figure 4.9. Upconversion emission of NaGdF4:Er3+/Yb3+ upconverting colloidal 
nanoparticles (1 wt% dispersion in toluene, λexc = 980 nm) prepared at precursor injection 
rates of 0.5-2.5 mL/min.  Upconversion emission was ascribed to the (i) 2H11/2 → 4I15/2, 



























 Following 980 nm excitation, upconversion emission of the erbium ion was 
observed with three distinct peaks assigned to the  2H11/2 → 4I15/2 transition centered at 
~520 nm (green emission), 4S3/2 → 4I15/2 transition centered at ~540 nm (green emission) 
and the 4F9/2 → 4I15/2 transition centered at ~675 nm (red emission). The upconversion 
emission of the Er3+/Yb3+ co-doped system occurs predominantly via an energy transfer 
mechanism. The energy transfer step is facilitated by Yb3+, which possesses a resonant 
energy level with both the pump photon (980 nm) and the 4I11/2 level of Er3+. The 
upconversion mechanism is shown in Figure 4.10 where in the first step, incoming pump 
photons will raise the Yb3+ ion to the 2F5/2 excited state. This is followed by an energy 
transfer from Yb3+ to the 4I11/2 level of Er3+. A second energy transfer from Yb3+ will 
populate the 4F7/2 level of Er3+ leading to the population of the close-lying 2H11/2 and 4S3/2 
states through non-radiative decay. This is followed by green upconversion emission and 
return of the Er3+ ion to the ground state. Red upconversion emission may occur through 
non-radiative decay from the 4S3/2 to the 4F9/2 state populating the latter and subsequent 
red emission as the Er3+ ion returns to the ground state. Alternatively, following 
population of the 4I11/2 level of Er3+, a non-radiative decay to the lower lying 4I13/2 will 
occur followed by an energy transfer from Yb3+, which populates the 4F9/2 state of Er3+ 





Figure 4.10. Energy transfer upconversion mechanism for NaGdF4:Er3+/Yb3+ 
upconverting colloidal nanoparticles. 
 
 The emission intensity decreased as a function of the increasing injection rate due 
to the decrease in the particle size. With decreasing particle size, an increase in the 
number of surface defects is expected leading to decreased luminescence intensity. 
Surface defects contribute to the increase in non-radiative pathways, which quench the 
luminescence of the dopant ions. This however does not hold true in the transition from 
the 0.5 to 1.0 mL/min injection rate where an increase in the overall emission intensity 
was observed and is due to the predominance of the hexagonal phase in the latter versus 
the cubic phase in the former. As previously explained, formation of the hexagonal phase 




 Normalizing the upconversion spectra to the 4S3/2 → 4I15/2 emission (as shown in 
Figure 4.9) indicated that the red to green emission ratio changed as a function of the 
increasing precursor addition rate. The cubic phase of NaGdF4 typically yields a stronger 
red component of the upconversion emission in comparison to the hexagonal phase. 
Hence as the cubic component decreased, so did the red emission character. No 
significant presence of the cubic phase (~5%) was observed in the XRD patterns of the 
samples prepared at 1.5-2.5 mL/min and in accordance, no significant changes in the 
red:green emission ratio were observed. The integrated emission intensity of the red and 
green emission peaks was calculated and a ratio of the red:green emission (I650/I540) was 
plotted as a function of the precursor injection rate (Figure 4.11). The red:green ratio 
continuously decreased up to the 1.5 mL/min addition rate after which minor variations 
were observed over the remainder of the conditions (1.5-2.5 mL/min). At the slowest 
injection rate, a red:green ratio of nearly 1.3:1 was observed and decreased two-fold by 
increasing the injection rate to 1.0 mL/min. Finally as the injection rate was increased to 
1.5-2.5 mL/min, the calculated ratio remained unchanged at a value of ~0.3. 
 Having evaluated multiple precursor injection rates, it was found that at 0.5 
mL/min, polydispersity was quite high with a mixture of cubic and hexagonal phases. A 
significant improvement in particle size and distribution was observed at 1.0 mL/min. 
The transition to 1.5-2.5 mL/min injection rates however yielded single phase 
(hexagonal), monodisperse nanoparticle with particles sizes ranging from 10-15 nm. 
Modulation of the precursor injection rate allows for the tuning of the particle size 
between 10-40 nm (2.5-1.0 mL/min). For biologically oriented applications as is the case 
of the present work, the targeted parent nanoparticle size is ≤ 20 nm. Further modification 
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of the nanoparticle through silica shell formation and surface functionalization is 
anticipated to result in further particle diameter increase reaching the 30-50 nm mark. 
This size is generally recognized as ideal with respect to cellular uptake [171]. As a 
result, the 1.5 mL/min precursor injection rate was selected for the remainder of the study 





Figure 4.11. The red:green luminescence ratio for NaGdF4:Er3+/Yb3+ upconverting 
colloidal nanoparticles as a function of the precursor addition rate (0.5-2.5 mL/min). 
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4.1.2 The Effect of the Reaction Temperature 
 
 The second parameter that was selected for evaluation was the reaction 
temperature. As the precursor addition rate was fixed at 1.5 mL/min and the reaction time 
maintained at 60 minutes, the reaction temperature was varied from 280-320 °C, in 10 °C 
increments. Temperature was expected to play a significant role during both nanoparticle 
nucleation and growth processes. The trifluoroacetate precursor decomposition is 
temperature dependent as mentioned in Section 4.1, and therefore reaction temperatures 
near or exceeding the decomposition point of the trifluoroacetates may potentially 
influence the resultant particle size, morphology, and phase. Five batches of nanoparticles 
synthesized at temperatures ranging from 280-320 °C were prepared and analyzed by 
TEM. The low and high resolution TEM images are summarized in Figure 4.12a and b, 
respectively where several notable changes in particle size and morphology were 
observed. For example, at 280 °C, the nanoparticles were highly polydisperse with sizes 
ranging from 5-20 nm and 60-80 nm. Moreover, a very important morphological change 
was observed for the NaGdF4:Er3+/Yb3+ nanoparticles, prepared at 280 °C, especially in 
comparison to the particles prepared at higher temperatures. At 280 °C, the resultant 
nanoparticles were mostly irregularly shaped with no distinct morphological features. In 
some cases, these irregularly shaped particles appeared to be agglomerated representing a 
collection of several particles fused together. Increasing the temperature to 290 °C 
resulted in an amelioration to both the particle size and morphology where polydispersity 
was reduced and the majority of the particles were <50 nm in size. From a morphological 
standpoint, the nanoparticles formed as rounded cubes at 290 °C. In the transition from 
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280 °C to 290 °C, the nanoparticles began to exhibit the self-assembly behaviour 
previously noted in Section 4.1.1. Upon further increase of the temperature to ≥300 °C, 
the nanoparticles formed became more uniform and monodisperse. At 300 °C, the 
nanoparticles were observed to be hexagonal in morphology with a particle size ranging 
from 10-30 nm. Increasing the temperature to 310 °C resulted in highly uniform 
nanoparticles ~ 15-20 nm in size. Lastly at 320 °C, while the nanoparticles formed were 
uniform and monodisperse, significant size differences were observed where the 
nanoparticles formed were ~70-90 nm in diameter. The TEM findings can be explained 
through a discussion of precursor decomposition, nucleation and growth and the effect 
that temperature plays in favouring one process over another.  
 At temperatures near the decomposition point, it would be expected that the 
trifluoroacetates do not decompose rapidly. This would directly impact both nucleation 
and growth. This was noted at 280 °C where the particles formed grew non-uniformly 
with a large size distribution. Initially, some nuclei will form and as other decomposing 
materials are introduced in the system, they can be used to either form new nuclei or to 
sustain the growth of the already formed nuclei sinks. At temperatures near the 
decomposition point, it is likely that a combination of both processes occurred explaining 
the size distribution and non-uniform growth. This is in accordance with the La Mer 
nucleation and growth model, which states that polydispersity occurs when the nucleation 
and growth do not occur in a discrete manner [122, 143, 172, 173]. At low temperatures, 











Figure 4.12. Transmission electron microscopy digital images of NaGdF4:Er3+/Yb3+ 
upconverting nanoparticles at (a) low magnification (22,000X) and (b) high 
magnification (97,000X) prepared as a function of reaction temperature (280-320 °C). 
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 At more elevated temperatures where decomposition of the precursors is achieved 
more rapidly, the rate of nucleation increases explaining the more homogeneous 
formation of particles and narrower distributions. This was observed most notably at 
290-310 °C. At these temperatures, a large number of nuclei likely formed rapidly 
resulting in a homogeneous growth process. Temperature control may however be used to 
favor growth over nucleation, such as in the case of the particles formed at 320 °C. At 
very high temperatures, the formed nuclei rapidly grew and as more precursor materials 
decomposed, they were used to sustain the growth process at the expense of the 
formation of new nuclei. The size distributions and mean particle size data are 
summarized in Figure 4.13 and Table 4.2, respectively. From the particle size distribution 
plots and the mean particle sizes shown below, a steady decrease in size was observed 
upon transitioning from 280 °C to 310 °C after which a significant increase in particle 
size was observed at 320 °C due to the preferential growth mechanism. Particle 
polydispersity at 280 and 290°C resulted in a double Gaussian peak fit to account for the 
broad particle size distribution. In contrast, single Gaussian peak fits were required at 
higher temperatures as the particles formed were monodisperse. The relative standard 
deviation associated with the particle size measurement was calculated to be ~60% of the 
mean particle size measured at 280 °C; this value decreased progressively as a function of 





Figure 4.13. Particle size distribution of NaGdF4:Er3+/Yb3+ upconverting nanoparticles 







Table 4.2. Mean particle size of NaGdF4:Er3+/Yb3+ upconverting nanoparticles prepared 
at different reaction temperatures (280-320 °C). 
Reaction 
Temperature  




36.4 ± 23.0 26.9 ± 9.3 18.9 ± 4.2 15.4 ± 1.9 80.7 ± 7.2 
 
  
 Electron diffraction analysis revealed that samples prepared in the range of 280-
320 °C were crystalline. The diffraction rings observed in Figure 4.14 also showed 
differences in the patterns as the reaction temperature increased. For example at 280 and 
290 °C, a similar pattern was observed relative to the sample prepared at 0.5 mL/min (see 
Figure 4.6) where both the cubic and hexagonal phases were indexed. It is likely that at 
sub 300 °C temperatures, the transition from the cubic to the hexagonal phase cannot be 
completed in the 1 hour reaction duration and may require longer times to complete the 
phase transition. It has been previously reported in the literature that conversion of the 
cubic to the hexagonal phase can be carried out via heating at elevated reaction 
temperatures (≥ 300 °C) as the nanoparticles require high temperatures to overcome the 
energy barrier and convert to the thermodynamically more stable hexagonal phase [122]. 
At temperatures of 280-290 °C, the energy barrier cannot be completely surpassed 
resulting in the mixture of phases observed. Furthermore, the presence of well resolved 
bright spots in the electron diffraction patterns of both samples at 280 and 290 °C 






Figure 4.14. Electron diffraction rings obtained by TEM for NaGdF4:Er3+/Yb3+ 
upconverting nanoparticles prepared as a function of reaction temperature (280-320 °C).  
 
  
 Further investigation of the crystal phases of the NaGdF4:Er3+/Yb3+ nanoparticles 
was extended to XRD studies (Figure 4.15). Indeed, following the completed reaction at 
280 °C, a mixture of cubic and hexagonal phases was observed with a dominant presence 
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of the hexagonal phase (as well as < 5% hexagonal phase GdF3). Conversely, a 
predominantly cubic phase pattern was observed at 290 °C with some hexagonal phase 
contribution indicated by the peaks observed at 31-32, 44 and 54 °2θ. This was 
unexpected given that the temperature increase should drive the formation of 
hexagonal-phase particles as they overcome the energy barrier for the cubic to hexagonal 
transition but in fact the opposite was observed. This effect has been previously reported 
by Wang et al. [121] for fluoride host materials where nanoparticles preferentially formed 
in the hexagonal phase when significant particle agglomeration or enlarged crystal size 
had occurred. For the sample prepared at 280 °C, this was noted based on the observed 
particle size as well as the irregularly shaped agglomerate-like materials. As the 
magnitude of these effects diminish at 290 °C, the hexagonal phase contribution becomes 
less important and the cubic phase forms. Further temperature increases to 300-320 °C 
resulted in the formation of the hexagonal phase with no significant cubic phase 
contribution. 
 As per the samples prepared at different precursor injection rates, Rietveld fitting 
was carried out on the XRD patterns in order to determine the cubic and hexagonal phase 
contributions. The fit results are plotted in Figure 4.16. At 280 °C, a 50% mixture of  both 
phases was observed. This in accordance with the XRD pattern, which showed that both 
cubic and hexagonal phase reflections were prominent. In contrast, at 290 °C, a rapid 
increase of the cubic phase content (~90%) was noted. Again, this was in agreement with 
the diffraction pattern where the presence of the hexagonal phase peaks decreased 
significantly in comparison to the cubic phase counterpart. Further increase in the 
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temperature to 300 °C and beyond resulted in a steep decrease of the cubic phase to a 
constant value of 5%. This was once again supported by the XRD results where no 




Figure 4.15. X-ray powder diffraction analysis of NaGdF4:Er3+/Yb3+ upconverting 
nanoparticles prepared at different reaction temperatures (280-320 °C). Peaks marked 
with "c", "h" and "*" are attributed to the cubic and hexagonal phases of NaGdF4 and the 
hexagonal phase of GdF3, respectively. Peaks in the diffraction pattern of the samples 
prepared at 300-320 °C are all attributed to the hexagonal phase. 
 
  































Figure 4.16. The cubic phase content of NaGdF4:Er3+/Yb3+ upconverting nanoparticles as 
a function of increasing reaction temperature (280-320 °C). 
  
 Changes in the upconversion luminescence were also evaluated as a function of 
reaction temperature and the results are shown in Figure 4.17. Similar emission features 
were observed relative to the samples prepared using various precursor injection rates 
(Section 4.1.1). It is noteworthy to mention that the lanthanide emissions are positionally 
unaffected by the particle size or morphological changes and hence similar spectra were 
observed.  
 




















Figure 4.17. Upconversion emission for NaGdF4:Er3+/Yb3+ upconverting colloidal 
nanoparticles (1 wt% dispersion in toluene, λexc = 980 nm) prepared at 280-320 °C.  
Upconversion emission was ascribed to the (i) 2H11/2 → 4I15/2, (ii) 4S3/2 → 4I15/2 and (iii) 
4F9/2 → 4I15/2 transitions. 
 
 
 Upon initial inspection of the emission spectra in Figure 4.17, no definitive trend 
relating the red:green emission ratios to the nanoparticle formation temperature could be 
observed. At 280 °C, the nanoparticles exhibited a strong red emission due to the cubic-
phase contribution. Increasing the reaction temperature to 290 °C resulted in a more 
dominant red:green ratio. This was in accordance with the XRD data and the Rietveld fits 
where the observed phase at this temperature was predominantly cubic hence explaining 



























°C resulted in almost identical emission profiles with a weaker red:green ratio. The 
hexagonal phase particles yield a strong green upconversion emission and hence these 
results fall within what was expected. Finally at 320 °C, where the particles formed were 
of the hexagonal phase and ~80 nm in diameter, a strong red emission component was 
once again observed with an increase in the red:green ratio (Figure 4.18). As no phase 
changes were observed by XRD, a low red:green ratio would have been expected to 
persist. This result can be explained through the change in the nanoparticle size. As the 
particle size increases, the surface area to volume ratio decreases implying that fewer 
oleate molecules would cap the nanoparticle surface and that non-radiative pathways may 
be enhanced due to the solvent phonon energies. This occurs due to a favoring of the 
direct population of the 4F9/2 energy level through the depopulation of 4I11/2 to 4I13/2 and a 
subsequent energy transfer from the Yb3+ ions. The maximum phonon energy of the 
colloidal dispersion medium, toluene, is 3100 cm-1, which can be used to mediate the 
energy gap separating the 4I11/2 and 4I13/2 states of the Er3+ ion. 
 At near precursor decomposition temperatures, the particles formed were highly 
polydisperse with no distinct morphological assignment. More importantly however, at 
temperatures greater than 280 °C, the reaction temperature allowed for the modulation of 
the particle size between 15-80 nm and resulted in monodisperse nanoparticles. As with 
the precursor injection rates evaluated in the previous section, modification of the 
reaction temperature added an additional measure of control over the nanoparticles 





Figure 4.18. The red:green luminescence ratio for NaGdF4:Er3+/Yb3+ upconverting 
colloidal nanoparticles as a function of reaction temperature (280-320°C). 
 
4.1.3 The Effect of the Reaction Time 
 
 The final parameter selected for optimization was the reaction time. This was 
carried out to investigate whether the change in reaction duration can impact the growth 
process and ultimately the particle size and crystal phase. The precursor injection rate and 
temperature parameters investigated in Sections 4.2.1 and 4.2.2 were maintained constant 
at 1.5 mL/min and 310 °C, respectively. Five batches of NaGdF4:Er3+/Yb3+ nanoparticles 
synthesized at reaction times ranging from 30-180 minutes were prepared and analyzed 















by TEM. The low and high resolution TEM images are summarized in Figure 4.19a and 
b, respectively. As the reaction duration was varied from 30-180 minutes, changes in the 
nanoparticle size were observed albeit to a much lesser extent to what was previously 
noted for the other parameters. Furthermore, the nanoparticles exhibited a very similar 
morphology throughout the different reaction times with hexagonal/rounded 
hexagonal-shaped particles noted in Figure 4.19. The nanoparticles remained highly 
monodisperse with no significant evidence of polydispersity. It is however important to 
note that with prolonged reaction time (t ≥120 minutes), the nanoparticles showed a slight 
agglomerative behaviour. This was attributed to potential oxidation of the oleate capping 
ligand, which is sensitive to prolonged exposure to heat.  
 Upon examination of the TEM images, it was observed that the particle size 
increases up to the 90-minute time point after which a decrease in the particle size was 
noted at 120 minutes. This was also confirmed by examining the mean particle size data 
(Table 4.3). A particle size of 12 nm was obtained after the reaction had proceeded for 30 
minutes. Afterwards, a steady increase in particle size was observed up to a value of 17.4 
nm at the 90-minute reaction time. This was immediately followed by a 6 nm decrease in 
particle size following a 120-minute heating period and once again re-growth upon 










Figure 4.19. Transmission electron microscopy digital images of NaGdF4:Er3+/Yb3+ 
upconverting nanoparticles at (a) low magnification (22,000X) and (b) high 
magnification (97,000X) prepared as a function of reaction time (30-180 min). 
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Table 4.3. Mean particle size of NaGdF4:Er3+/Yb3+ upconverting nanoparticles prepared 
at different reaction times (30-180 minutes). 
Reaction 
Time  




12.1 ± 2.5 15.4 ± 1.9 17.4 ± 2.8 10.6 ± 1.7 15.7 ± 2.3 
 
 
These observation stem from the fact that the NaGdF4 growth process occurs through 
Ostwald ripening where, following nucleation and initial growth, the nanoparticles 
continue to grow as a function of time. This however does not account for the decrease in 
particle size after a 120-minute reaction time. During the Ostwald ripening process and 
over a period of time, smaller particles dissolve and this dissolved material is used to 
support the growth process of the larger particles. In the case of sub-20 nm particles 
where the difference between smaller and larger particles is "small", all particles may be 
susceptible to dissolution and eventual uniform re-growth as observed after a 180-minute 
reaction time. In such cases, the kinetics differ relative to those of the bulk phase (>100 
nm), which explains the overall decrease in particle size and uniform re-growth [174, 
175]. 
 Throughout the course of the reaction time, the nanoparticles formed were highly 
monodisperse as seen in the distributions in Figure 4.20. In fact, all particle size 
distributions could be fitted to a single Gaussian peak. This suggested that reaction 





Figure 4.20. Particle size distribution of NaGdF4:Er3+/Yb3+ upconverting nanoparticles 






 Evaluation of the electron diffraction results indicated that no significant phase 
changes occurred as a function of reaction time (Figure 4.21). All diffraction rings were 




Figure 4.21. Electron diffraction rings obtained by TEM for NaGdF4:Er3+/Yb3+ 
upconverting nanoparticles prepared as a function of reaction time (30-180 minutes).  
98 
 
 The electron diffraction results were also confirmed using XRD (Figure 4.22), 
where the NaGdF4 nanoparticles were observed to be of the hexagonal phase. The 
Rietveld fitting of the XRD data (Figure 4.23) showed several similarities to the XRD 
results with the exception of the results obtained at 30 minutes, where ~30% cubic phase 
content was observed. As the reaction time increased, the cubic phase content decreased 




Figure 4.22. X-ray powder diffraction analysis of NaGdF4:Er3+/Yb3+ upconverting 
nanoparticles prepared at different reaction temperatures (30-180 min). Peaks marked by 
a "*" are attributed to the hexagonal GdF3 phase. 





















Figure 4.23. The cubic phase content for NaGdF4:Er3+/Yb3+ upconverting nanoparticles 
as a function of increasing reaction time (30-180 min). Note the scale was kept constant 
for ease of comparison to Figures 4.8b and 4.16. 
 
 The upconversion luminescence was also evaluated as a function of the reaction 
duration (Figure 4.24). No significant changes were observed in the emission profiles 
with the exception of the sample at the 30-minute reaction time, which showed a slightly 
more intense red emission. This is due to the higher cubic content as demonstrated 
through the Rietveld fitting. As the reaction time increased, the red emission intensity 
decreased due to the formation of the hexagonal phase and the absence of the cubic phase 
counterpart. Further increase of the reaction time did not lead to significant changes in 
the red:green emission ratio, which remained relatively constant (Figure 4.25). In fact for 



















nanoparticles prepared between 60 and 180 minutes, the variation of the red:green 




Figure 4.24. Upconversion emission of NaGdF4:Er3+/Yb3+ upconverting colloidal 
nanoparticles (1 wt% dispersion in toluene, λexc = 980 nm) prepared using 30-180 minute 
reaction times. Upconversion emission was ascribed to the (i) 2H11/2 → 4I15/2, (ii) 4S3/2 → 
4I15/2 and (iii) 4F9/2 → 4I15/2 transitions. 
 
 





























Figure 4.25. The red:green upconversion luminescence ratio for NaGdF4:Er3+/Yb3+ 
upconverting colloidal nanoparticles as a function of reaction temperature (30-180 min). 
 
4.2 Thermal decomposition as a Tool to Modulate Nanoparticle size 
 
 The reaction temperature, time and rate of precursor addition strongly influence 
the nanoparticle size, phase and morphology. By varying the experimental conditions, 
nanoparticles in the size range of 10-80 nm may be prepared. This in turn translates to the 
ability to tailor the nanoparticles towards specific application requirements. Table 4.4 
summarizes some of the conditions that can be used to obtain monodisperse nanoparticles 
in the sizes discussed above. 














Table 4.4. Summary of selected experimental conditions used to obtain monodisperse 










2.5 310 60 9.4 ± 1.5 
2.0 310 60 12.4 ± 1.3 
1.5 310 60 15.4 ± 1.9 
1.5 310 90 17.4 ± 2.8 
1.5 290 60 26.9 ± 9.3 
1.0 310 60 42.1 ± 3.1 
1.5 320 60 80.7 ± 7.2 
 
 
 Particle size control can offer several advantages particularly regarding 
technology and application development. For example, for novel thin displays, 80-nm 
sized nanoparticles, which are intense upconversion emitters, would be ideal particularly 
when compared to conventional micron-sized bulk materials. Preparing these 
nanoparticles using different dopant ions (such as Er3+, Tm3+ and Ho3+) can result in the 
preparation of red, green and blue emitters typically used in displays.  
 Particles in the 10-50 nm domain are considered ideal for in vitro and in vivo 
applications where they can be used for imaging, targeting and therapeutic applications 
[26, 58, 59, 63, 64, 66, 67, 73, 80, 88, 91, 92, 94, 167].  
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Chapter 5 - Orthogonal Surface Modification and Functionalization of 
Lanthanide-doped Upconverting Nanoparticles 
 
 The synthesis of lanthanide-doped nanoparticles investigated and optimized in 
Chapter 4 yielded monodisperse colloidal upconverting nanoparticles. These hydrophobic 
oleate-capped nanoparticles are dispersible in non-polar solvents such as toluene and 
hexane. The synthesis investigated in Chapter 4 also provided the capability of 
synthesizing nanoparticles in a wide range of sizes allowing for the tailoring of the 
particle size. While for certain applications, hydrophobic nanoparticles may be suitable 
[176], the work proposed in this thesis aims at developing multimodal nanoparticle 
systems for biological applications. Hence, colloidal dispersibility in non-polar (non-
aqueous) media is an important issue, which needs to be addressed through post synthetic 
modifications. Therefore, the nanoparticles synthesized require modification allowing for 
a facile dispersion in biorelevant media. 
 Particles prepared through the thermal decomposition synthesis are amenable to 
post synthetic modifications as they are capped with an organic oleate ligand. This 
capping ligand may be modified to achieve water dispersibility through a myriad of 
approaches, namely exchange [160, 177] or removal (through silica coating) [56, 76, 84, 
87, 120] of the oleate molecules. The former is discussed in detail in Chapter 6 where a 
ligand exchange with citrate-capped molecules yielded water dispersible nanoparticles. 




5.1. Silica Coating - Towards Water Dispersibility and Surface Functionalization 
 Silica coating, through silica shell formation, is considered to be a suitable 
approach towards achieving water dispersibility for two principal reasons. Firstly, the 
formed shell is grown on the nanoparticle core resulting in the formation of a surface 
with a high physical integrity. This is unlike electrostatic interactions, which govern the 
capping of ligands to a charged nanoparticle surface and which may be susceptible to loss 
or removal even under certain experimental conditions (pH and temperature). This is not 
the case for silica coated nanoparticles and hence it is considered to be a robust surface 
modification technique. Secondly, the formation of a silica shell results in the formation 
of an Si-OH surface allowing for additional surface chemistry to be carried out as will be 
discussed below. 
 The formation of a silica shell around the nanoparticle core was carried out using 
a reverse micro-emulsion technique. This was first reported by Stöber et al. [178] who 
used this approach to prepare silica microparticles. This technique has been modified 
where nanoparticles are included in the reaction to allow for the formation of a silica 
shell around the nanoparticle core. Formation of the silica shell occurs through the 
hydrolysis of tetraethylorthosilicate (TEOS) in the presence of a base catalyst such as 
ammonium hydroxide, a surfactant and the non-polar oleate-capped nanoparticles (Figure 
5.1). In this reaction, the hydrophobic nanoparticles are dispersed in a non-polar solvent 
such as cyclohexane, containing surfactant molecules, which may partially replace the 
non-polar oleate ligands. Immediately following this step, an aqueous base solution as 
well as TEOS are added to the reaction mixture. The base catalyzes the hydrolysis of the 




Figure 5.1. The formation of a silica shell surrounding an oleate-capped nanoparticle. 




Scheme 5.1. Base-catalyzed hydrolysis of TEOS during the silica coating process. 
 
Following hydrolysis of the TEOS molecule, the Si(OH)4 groups will commence to 
condense on the nanoparticle surface and result in the formation of a silica shell. The 
now-hydrophilic silica-coated nanoparticle locates itself within the surfactant micelles as 
the surrounding environment is hydrophobic due to the presence of cyclohexane and 
non-hydrolyzed TEOS molecules. The nanoparticles are then isolated via precipitation 















Si(OC2H5)4 +   4H2O                         Si(OH)4 +   4C2H5OH
NH4OH
Si(OH)4 +   Si(OH)4  (OH)3-Si-O-Si(OH)3 +   H2O
NH4OH




unreacted materials. The silica coating process is typically carried out for 48 hours to 
ensure complete shell formation surrounding the nanoparticle core. The recovered silica-
coated particles possess -OH surface functional groups which can be used for further 
surface modifications. 
 The ability to form monodisperse silica-coated nanoparticles with a uniform shell 
thickness offers a number of challenges particularly attributed to the minimization of 
agglomeration and multi-particle coating and encapsulation in a single shell. Initial 
attempts to prepare silica coated nanoparticles resulted in the formation of large 
agglomerates, which were unevenly coated (Figure 5.2).  
 
 




 It was observed that a cluster of lanthanide-doped nanoparticles were enrobed in a 
shell of silica, while others were formed as more individual and discrete entities. The 
sizes of the agglomerates were approximately a few hundred nanometers in diameter. 
This particle agglomeration had a direct impact on the colloidal dispersibility and 
stability of the nanoparticles in aqueous dispersions with precipitation occurring in less 
than 30 minutes. In order to mitigate the agglomeration and poor colloidal dispersion 
behaviour, the silica coating process of the lanthanide-doped nanoparticles was 
thoroughly studied in order to achieve monodispersity and colloidal stability in aqueous 
media.  
5.2 Monodisperse Silica Coated NaGdF4 Nanoparticles 
 Preliminary experimental investigations where the level of TEOS was varied 
resulted in a marked improvement to the silica coating procedure over initial attempts 
such as that shown in Figure 5.2; however, in order to try to achieve a high level of 
discrete particle coating and minimize agglomeration, a detailed study was carried out to 
evaluate the influence of the reactant concentrations on the coating process. In Figures 
5.3a-c are three sets of silica coating results carried out by varying the experimental 
conditions namely the TEOS and surfactant (Igepal CO-520) concentrations as well as 
the reaction time. Firstly, TEOS amounts of 1.4x10-5 M to 5.6x10-5 M were added to 
NaGdF4 nanoparticle dispersions (12-15 nm in size, 3mg/mL) while maintaining the 
surfactant and reaction time constant. Subsequently, the surfactant and reaction times 













Figure 5.3. TEM digital images (41,000X magnification) of silica coated nanoparticle 
prepared as a function of (a) TEOS concentration, (b) Igepal CO-520 concentration and 
(c) reaction time.  
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 At low TEOS concentrations ranging from 1.4 to 2.8x10-5 M, the TEM images 
revealed that a thin silica shell, ~2-3.5 nm in thickness, was formed surrounding the 
nanoparticle core; however, the silica coated particles were not monodisperse and did not 
form individual single core/single shell entities. In fact, the particles appeared to form 
conjointly with neighbouring particles within a long silica shell ribbon. This is 




Figure 5.4. TEM digital image depicting silica shell formation at low TEOS 
concentrations (97,000X magnification). 
 
 As the concentration of TEOS was increased to 3.4x10-5 M, the occurrence of 
individual core/shell nanoparticles was observed with a shell thickness of 4-5 nm; 
however the level of agglomeration remained elevated as the TEOS concentration used 
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was lower than required to form the uniformly coated particles. Hence, there was a 
deficiency of TEOS molecules, which can hydrolyze and condense on the surface of the 
nanoparticles to form single core/shell entities. The TEOS concentration was further 
increased to 4.3x10-5 M and the shell thickness decreased to a value of ~4 nm. At this 
stage, discrete core/shell particles appeared to form with minimal agglomeration. This 
trend of improved silica shell formation and decrease in agglomeration as a function of 
increased TEOS concentration, has been previously reported for other types of 
nanoparticles [181]. At 5.6x10-5 M TEOS concentration, the silica shell formed grew with 
a measured thickness of 6-15 nm. Furthermore, a large number of silica agglomerates of 
3-15 particles was observed as seen in the TEM image in Figure 5.3 a. The agglomerates 
ranged in size from 30-150 nm as several particles were engulfed in the thick shell. 
Figure 5.5 summarizes the silica shell thickness as a function of TEOS concentration. 
 
 
Figure 5.5. The silica shell thickness as a function of TEOS concentration. 
 




















TEOS Concentration (x10-5 M)
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 The effect of the surfactant concentration was also evaluated to determine its 
impact on the silica shell formation (Figure 5.3b). This was carried out using a 4.3x10-5 
M concentration of TEOS, which showed the thinnest silica shell with fewest instances of 
agglomeration and a 48-hour reaction time. Based on the TEM findings in Figure 5.3b, 
there were no significant differences between the lowest and highest surfactant 
concentrations ranging from 1.4 to 7.1x10-1 M with respect to shell thickness or particle 
agglomeration. This suggested that at the surfactant concentrations used, its effect was 
less important relative to that of the TEOS concentration. A summary of the silica shell 




Figure 5.6. The silica shell thickness as a function of Igepal CO-520 surfactant 
concentration. Note that the y-axis scale is similar to that used in Figure 5.5. 
 
 At the highest surfactant concentration, the thinnest silica shell was observed; 
however, it is noteworthy to mention that the difference relative to other surfactant 




















Igepal CO-520 Concentration (x10-1 M)
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concentrations amounted to ~0.7 nm in shell thickness. This value falls within the 
experimental error depicting the variation in the shell thickness for the samples measured 
at various surfactant concentrations. 
 Finally, the impact of the silica coating time was evaluated as shown in Figure 
5.3c (4.3x 10-5 M TEOS and 7.1x10-1 M Igepal CO-520 concentrations). The reaction 
time was varied from 4-48 hours. At the shortest reaction period, high magnification 
TEM images revealed that even though the coating appeared uniform, the particles were 
encapsulated alongside their neighbours in a continuous shell (Figure 5.7). As the 
reaction time increased to 8 hours, an increase in the silica shell thickness was noted; 
however, the particles appeared to form as agglomerates in large silica networks 
indicating that discrete core/shell units had not yet formed. Increasing the reaction time to 
16-48 hours resulted in the formation of discrete core/shell nanoparticles and a decrease 
in the agglomerative behaviour that was observed at the 4 and 8 hour time points. Minor 
differences were observed between the 16-48 hours time points (Figure 5.8) with a slight 
decrease in shell thickness observed at the longest time point. Following this study, the 
optimum silica coating conditions were determined to be based on using a 5.6x10-5 M 




Figure 5.7. TEM digital image depicting silica shell formation after 4 hours of reaction 





Figure 5.8. The silica shell thickness as a function of coating time. Note that the y-axis 
scale is similar to that used in Figures 5.5. and 5.6. 
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All nanoparticle surface modifications reported in this chapter were carried out using 
silica-coated particles prepared using these conditions. 
 
5.3 Fourier Transform Infrared Spectroscopy Analysis of Silica-Coated 
Nanoparticles 
 
 Following silica-coating optimization of the lanthanide-doped nanoparticles and 
shell-thickness characterization through TEM imaging, the resultant coated particles were 
analyzed using Fourier-transform infrared (FT-IR) spectroscopy to monitor the changes 
following the coating process. From the schematic shown in Figure 5.1, the oleate 
capping ligand is lost during this process and all signals attributed to the C-H and COO- 
stretches should in fact be absent for the coated particles. This was in fact confirmed in 
Figure 5.9 where the FT-IR spectra of oleate-capped and silica-coated nanoparticles are 
shown. The FT-IR bands in Figure 5.9a corresponded to the various stretching and 
bending vibrations due to the oleate molecules capping the nanoparticle surface. 
Specifically, the peaks at 2925 and 2855 cm-1 corresponded to the asymmetric and 
symmetric CH2 stretches of the sp3 hybridized carbons of the oleate molecule. A very 
weak vibration was also observed at 3004 cm-1 and was attributed to the sp2 C-H 
stretching of the alkene moiety of the oleate molecule. The bands observed at 1564 and 
1467 cm-1 were attributed to the asymmetric and symmetric COO- stretches, respectively, 
while those observed at 1165 and 720 cm-1 were ascribed to the -CH2 bending. Upon 
silica coating of the nanoparticles, a change in the FT-IR spectrum was observed (Figure 
5.9 b). For example, a broad stretch was noted at 3500 cm-1 and was assigned to the O-H 
stretching on the surface of the silica while the O-H bending was observed at 1594 cm-1. 
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The Si-C deformation and Si-O-Si stretching bands were observed at 1228 and 1096 cm-
1, respectively. Finally, the Si-C stretch was assigned to the band at 840 cm-1. The bands 
previously observed at 3004, 2925 and 2855 cm-1 assigned to the sp2 and sp3 hybridized 
C-H bonds of the CH2 groups of the oleate chains, were no longer present indicating that 
the oleate capping ligand had been removed and replaced by the silica shell. This was 
further supported by the absence of the COO- stretches, as well as the CH2 bending bands 
































5.4 Orthogonal Surface Functionalization of the Silica Surface 
 
 The presence of a silica shell can be viewed as an important scaffold on which 
additional chemical groups can be introduced and utilized for surface chemistry. While 
the silica shell does possess -OH surface functional groups, much of the current 
chemistry regarding functionalization of silica surface relies on the more convenient 
amine functionalized silica surfaces [182]. This is particularly true for biologically 
oriented applications where a large majority of the molecules of interest (targeting agents, 
biomolecules such as biotin, amino acids for example) can be functionalized to 
amine-functionalized silica surfaces through amide bond formation.  
 Much of the current scientific literature has focused on the use of silica-coated 
nanoparticles for imaging applications with particular emphasis on in vitro and in vivo 
imaging [61, 180, 182]. While the luminescent properties of many of these studied 
systems offer imaging capability, the crux remains the chemical modification of the 
nanoparticle surfaces as a means to establish and integrate multi-modality allowing for 
the extension of capabilities beyond imaging. Most of the existing multi-modal systems 
rely on grafting two functionalities to a single chemical group (typically amine groups) 
covalently bonded to the surface, thereby creating a competition in the grafting 
procedure. In some cases, the third functionality is only weakly bonded (physical 
adsorption on the nanoparticle) [56, 87]. Hence, the ability to decorate the silica surface 
with multiple functional groups can result in a more controlled surface modification, as 




 The functionalization of the silica-coated surface using these two differing 
molecules also introduces the notion of “orthogonality” to the nanoparticle surface 
chemistry. The orthogonal approach allows for the elimination of competitive grafting 
mechanisms (Figure 5.10) whereby two different and distinct functional groups are 
grafted to the nanoparticle surface each to be specifically reacted with two different and 
distinct molecules with no potential for chemical overlap [183]. This also ensures a strict 
measure of control and specificity of the surface chemistry of the nanoparticle.  
 
 
Figure 5.10. Surface modification of a silica coated nanoparticle surface using (A) 
mono-functionalized silica with surface group 1 and (B) orthogonally functionalized 
silica with surface groups 1 and 2. Surface groups 1 and 2 possess chemical specificity 
and will each react with only one terminal functional group that is chemically compatible.   
 
Mono-functionalized silica surface Di-functionalized silica surface




 The surface of the optimized NaGdF4:Tm3+/Yb3+ silica-coated nanoparticles, 
characterized in Sections 5.2 and 5.3, was modified using 
(3-aminopropyl)trimethoxylsilane (APTMS) and (3-azidopropyl)triethoxylsilane 
(AzPTES) bearing NH2 and N3 terminal groups, respectively. This exploits the natural 
tendency of the aforementioned molecules to graft on the silica surface via a silanol 
condensation reaction (Scheme 5.2). The silanol condensation reaction is an acid 
catalyzed reaction and results in the formation of Si-O-Si bonds where the terminal 




Scheme 5.2. The silanol condensation reaction resulting in the orthogonal surface 
















































































































 The acid catalyzes the hydrolysis of the ethoxy (or methoxy) groups of the silane 
reagents resulting in the formation of terminal silanol groups. Upon addition of a 
dispersion of silica-coated nanoparticles to the reaction mixture, the silanol groups will 
condense on the silica-coated nanoparticle surface to form an Si-O-Si network bearing 
amine and azide termini. The condensation of both silane reagents onto the silica coated 
surface was monitored through FT-IR spectroscopy and changes in the spectra were used 
to confirm the successful condensation of the amine and azide molecules (Figure 5.11).  
The resultant FT-IR spectrum shows similarities to its silica coated counterpart (Figure 





Figure 5.11. FT-IR spectrum of amine and azide functionalized nanoparticles following 
condensation of the silane reagents on the silica surface. 
 













                         
















 Three principal differences were observed relative to the FT-IR spectrum of silica 
coated nanoparticles, most notably as a second overlapping broad shoulder at ~3300 cm-1 
ascribed to the N-H stretching, a weak band at 2106 cm-1 assigned to N≡N stretching and 
lastly a band at 1360 cm-1 due to the C-N stretching of the carbon-amine bonds. Further 
investigation of the surface modification of the silane reagents was carried out via the use 
of the ninhydrin test using a bluish/purplish colour change (Ruhemann's purple) as an 
indication of the presence of a primary amine [184]. In order to quantify the silane 
surface coverage, a standard curve was prepared using serine, an amino acid that 
possesses a primary amine. The UV spectra obtained following analysis of the standard 
solutions are shown in Figure 5.12. As the amine standard concentration increased, the 
intensity of the bluish/purplish colour was observed to increase accordingly. A standard 
calibration curve was prepared and is shown in Figure 5.13. A linear fit was obtained with 
a correlation coefficient of 0.9912. Silica coated nanoparticles bearing 100% amine 
(prepared using APTMS) and 50% amine groups (prepared using  APTMS  and AzPTES) 
were analyzed, and a measure of the amine surface concentration was obtained. The 
sample functionalized using the amino silane reagent was calculated to contain 1.38x10-6 
mol amine where as the sample prepared using the a 50:50 mixture of the amino and 
azido silane reagents was calculated to contain 8x10-7 mol of amine. The decrease in the 
amine surface coverage was expected as the azido silane reagent was also present on the 
surface of the nanoparticle and does not yield a positive test on reaction with ninhydrin. A 
50% decrease in amine concentration would have been expected to yield a value of 
6.9x10-7 mol; however, the observed value was slightly higher and may be due to an error 
in the measurement given the very low quantity of amine groups present at the surface of 
123 
 
the silica coated nanoparticle surface. Based on the values obtained through the 
calibration curve above, and knowing the quantity of nanoparticles used in the unknown 
samples (10 mg), the amine surface coverage was calculated per nanoparticle and a value 
of 2.4 x10-21 and 1.4 x10-21 mol/nanoparticle for the 100% and 50% aminated surfaces, 




Figure 5.12. The increase in the absorbance peak, indicative of a positive ninhydrin test, 
as a function of increasing amine standard concentration. 
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Figure 5.13. Standard calibration curve for the detection of primary amines using the 
ninhydrin test. 
 
5.5 Surface Modification of the Amine/Azide Silica-Coated Nanoparticles 
 
 Following the orthogonal functionalization of the silica-coated nanoparticle 
surface, functionalization using molecules capable of imparting novel modalities to the 
nanoparticle became feasible. As previously mentioned, the orthogonal surface 
modification approach allows for the multiple and concomitant nanoparticle surface 
functionalization with various organic molecules as long as the chemical groups (NH2 
and N3) on the nanoparticle surface are compatible with the appropriate counterparts to 
be functionalized. For example, the presence of the amine groups on the nanoparticle 
requires a carboxylic acid group for an amide bond formation, while the azide surface 












groups can undergo a 1,3-dipolar cycloaddition, also known as the "Click" reaction, when 
reacted with an alkyne-bearing molecule.  
 The ability to carry out the surface functionalization of the nanoparticle was 
investigated using two model molecules namely folic acid and cis-platinum (Figure 5.14a 
and b). These two molecules were selected to demonstrate that these nanoparticles may 
be functionalized with targeting and therapeutic modalities. Folic acid is recognized by 
over-expressed folate receptors on many cancer cells and hence is a suitable candidate for 
cancer cell targeting. From a chemical perspective, it is a well-studied molecule with 
known physico-chemical properties and is therefore a model candidate for the work 
reported herein. Similarly, cis-platinum is a well-recognized molecule in chemotherapy 
and has been a corner stone in cancer treatment that in fact, it is still used to date. Like 
folic acid, it is well studied and its physico-chemical properties have been reported in 
depth [185, 186]. In order to accommodate the surface functionalities that were endowed 
upon the nanoparticle, it was evident that both molecules required modification in order 
for a reaction to proceed with the amine and azide groups on the nanoparticle surface. 
Chemical modification of the folic acid to yield a folate derivative with a terminal alkyne 
(Figure 5.14 c) was envisioned to result in a reaction with the azide-terminated silane 
reagent on the nanoparticle surface. In contrast, the reaction of cis-platinum with the 
nanoparticle surface would not likely proceed as the Pt-N coordination bond is quite 
strong (42.5 kcal/mol) and would not likely undergo a reaction [187]. Hence, a precursor 
to the formation of cis-platinum, potassium tetrachloroplatinate (K2PtCl4), was selected 
for the reaction (Figure 5.14 d) with the amine-modified portion of the nanoparticle 




Figure 5.14. Molecular structures of (a) folic acid and (b) cis-platinum, (c) propargyl 
folate and (d) potassium tetrachloroplatinate. 
 
5.5.1 Preparation of the Alkyne Terminated Folate Derivative 
 The conversion of folic acid to an alkyne-terminated form, propargyl folate, 
occurs via the reaction of folic acid with propargyl amine. A summary of the reaction is 










































Scheme 5.3. The reaction of folic acid with EDAC, NHS and propargylamine for the 
formation of propargyl folate. In the second step of the reaction, the pteroate moiety of 
the molecule was replaced by R for purposes of clarity. 
 
The introduction of the propargyl amine moiety occurs through an amide bond formation 
using both 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDAC) and 
N-hydroxysuccinimide (NHS). The reaction of folic acid with EDAC results in the 
formation of an O-acylisourea active intermediate, which is prone to rapid hydrolysis. 
Hence, NHS is used to form a more stable ester active intermediate followed by the 
addition of the propargyl amine and the formation of propargyl folate [188]. 
Characterization of the propargyl folate product was carried out using FT-IR and 1H 


































































From the FT-IR plot in Figure 5.15, several differences were observed relative to the 
starting folic acid parent molecule. The first difference was a band observed at 3290 cm-1 
in the spectrum of propargyl folate, which was attributed to the intense ≡C-H stretching 
of the alkyne moiety of the molecule. In addition, the characteristic weak C≡C stretch 
was observed at 2160 cm-1. Two other notable changes were observed relative to the 
parent FT-IR spectrum namely the change in band profile at 1700 cm-1 and the broad 
band at 650 cm-1 attributed to the C=O stretching of the amide bond and the ≡C-H 
bending, respectively [189, 190]. 
 
 
Figure 5.15. FT-IR spectra of (a) propargyl folate and (b) folic acid. 
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 Further characterization of the folic acid derivative was carried out using proton 
NMR spectroscopy (Figure 5.16). Comparison to the parent folic acid molecule revealed 
several important differences, most notably a doublet between 3.05-3.10 corresponding to 
the terminal alkyne group proton (≡C-H group, 1H), which is present following reaction 
of the propargylamine reagent with either of the -COOH groups (α or γ positions) of folic 
acid. In addition, the multiplet at 3.78-3.84 ppm was attributed to the -CH2 protons of the 
propargyl group (-CONH-CH2C≡CH, 2H, J = 2.6 Hz at either the α or γ position). 
Successful preparation of the propargyl folate molecule was also confirmed using 13C 
NMR where signals at 73 and 82 ppm were observed corresponding to the -C≡CH and -
C≡CH carbons, respectively.  
 
  
Figure 5.16. 1H NMR spectra of (a) propargyl folate and (b) folic acid.  
  













 The NMR data reported above were in accordance with previous reports regarding 
alkyne modification of folic acid [189, 190]. It is noteworthy to mention that 
functionalization of the folate molecule with propargylamine at either carboxylic acid 
position (α or γ position) would not be expected to impact its targeting capabilities. In 
fact, several works in the literature have reported successful targeting capabilities 
regardless of whether the folic acid molecule was modified at the α or γ-COOH position 
[191-193]. The targeting moiety of folic acid is the pteroate portion, which recognizes 
over-expressed folate receptors on certain cancer cell lines [194]. This portion of the 
molecule was not involved in the course of the reaction and hence would be expected to 
maintain its functionality. 
 
5.5.2 Conjugation of a cis-Platinum Analogue to the Nanoparticle Surface 
 
 The functionalization of potassium tetrachloroplatinate to the nanoparticle surface 
was firstly carried out on a nanoparticle surface that was solely modified with an 
aminosilane reagent. This was carried out in order to clearly establish whether the 
reaction was feasible and whether a cis-platinum-like analogue would be obtained. In 
addition, the initial characterization of the platinum-functionalized surface could be 
carried out with greater ease in order to study the reaction at hand. The reaction of the 
platinum salt on the nanoparticle surface to yield a cis-platinum analogue was carried out 
as shown in Scheme 5.4. In the proposed reaction, the platinum salt is stirred with a 
nanoparticle suspension in water/methanol (at room temperature) and would lose 2 Cl- 
ligands to form a coordination bond with the lone pair of the nitrogen atoms (on the 
nanoparticle surface) to yield a cis-platinum analogue. The proposed structure of the 
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platinum molecule on the nanoparticle in Scheme 5.4 is similar to the structure of cis-
platinum shown in Figure 5.14 b. 
 
 
Scheme 5.4. Reaction of potassium tetrachloroplatinate with an aminated nanoparticle 
surface to yield a cis-platinum-like analogue on the nanoparticle surface. 
  
 Following this reaction, the isolated nanoparticles were analyzed using X-ray 
photoelectron spectroscopy (XPS) and inductively coupled plasma - atomic emission 
spectroscopy (ICP-AES) in order to 1) confirm the presence of the platinum species on 
the nanoparticle surface, 2) measure the platinum surface coverage and 3) quantify the 
extent of Cl- substitution on the surface. The latter was carried out to achieve an 
understanding of how the molecule can bond to the nanoparticle surface i.e. via 1, 2, 3 or 
even 4 amine groups (through the loss of Cl- ligands). The isolated platinum-modified 
nanoparticles were analyzed using XPS (Figure 5.17) in order to confirm the presence of 
the platinum species as well as to obtain a measure of the Pt:Cl stoichiometry. The XPS 
beam can be used to harvest important chemical information from the surface (~1-2 nm) 
[195]. The XPS wide-scan survey is shown in Figure 5.17a, where the signal was 
assigned to the various elements present in the nanoparticle based on the binding energy 
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(in eV) at which they were observed. Of great prominence were the Si peaks (102.2 (Si 
2p) and 156.6 eV (Si 2s)) attributed to the silica shell present on the nanoparticle surface. 
Moreover, a weak nitrogen peak was observed at ~398 eV and is attributed to the N 
atoms of the amino silane. In addition, Pt peaks were observed at 72-75.5 (Pt 4f), 316.6 
(Pt 4d5/2), 332.8 (Pt 4d3/2) and 522.0 eV (Pt 4p3/2) while a single Cl peak was noted at 




Figure 5.17. XPS analysis of (a) platinum functionalized nanoparticles, (b) high 
resolution scan of the Pt 4f peak and (c) high resolution scan of the Cl 2p peak. 
 
 The wide-scan survey was used to confirm the presence of the platinum species 
on the nanoparticle surface; however, no information could be directly extracted 
regarding the stoichiometry of the platinum and chlorine atoms that can explain the 





resolution scans of the Pt 4f and Cl 2p peaks were performed in order to try to 
quantitatively determine the stoichiometry of the two elements. The Pt 4f signal was 
selected as it offered no interference with other neighbouring peaks and hence would 
offer better precision for quantitative analysis. Three samples were evaluated and 
compared namely potassium tetrachloroplatinate (starting material), cis-platinum (an 
analogue of which is being formed on the nanoparticle surface), as well as the platinum 
modified nanoparticles (final product). The high-resolution XPS scans (Figure 5.17 b and 
c) were used to calculate percent atomic concentrations of the Pt and Cl atoms, which 
were then calculated as ratios and are summarized in Table 5.1. Values of atomic percent 
concentration used to calculate the ratios were obtained following application of the 
relative sensitivity factors (RSF = 0.73 for Cl2p and RSF = 4.4 for Pt 4f) in order to 
correct for the signal sensitivity of each element ensuring that the integrated signal 
intensity reflects the amount of material present on the sample surface. 
 
Table 5.1. Chlorine to platinum ratio for the potassium tetrachloroplatinate starting 
reagent, cis-platinum and nanoparticles modified with a cis-platinum analogue. 








The starting reagent showed a Cl:Pt ratio of 4.4:1, which is consistent with the presence 
of 4 Cl atoms to one 1 Pt atom. The cis-platinum compound showed a ratio of 2.2:1, 
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again consistent with the expected ratio since the molecule has two Cl- ligands to one Pt 
atom. Lastly the platinum-modified nanoparticles showed a Cl:Pt ratio of 1.7:1, which is 
consistent with the presence of 2 Cl- ligands to one Pt atom. The observed value was 
lower than the expected value of 2 suggesting that some Pt molecules may be coordinated 
to the nanoparticle surface via more than 2 amine groups. 
 Further analysis of the platinum-modified nanoparticles was carried out using 
ICP-AES to determine the platinum coverage on the nanoparticle surface. A calibration 
curve (Figure 5.18) was first developed using cis-platinum (0.05-10 ppm concentrations) 
as the standard reagent prior  to the characterization of the platinum-modified 
nanoparticles. The obtained curve showed a high degree of linearity with a correlation 
coefficient of nearly 1. Cis-platinum was used as the standard reagent in this case as the 
platinum-modified nanoparticles would bear an analogous molecule on the surface.  
 
 
Figure 5.18. ICP-AES calibration curve prepared using cis-platinum as a standard 
reagent. 


























 Subsequently, a platinum loading study was carried out to study the surface 
coverage of the cis-platinum analogue on the nanoparticle surface. A concentrated 
standard solution of K2PtCl4 (0.0215 M) was prepared after which various aliquots (50 – 
250 µL) were added to colloidal dispersions of the nanoparticles. ICP-AES analysis 
showed that the platinum coverage (concentration) increased in a linear fashion as the 
volume of the concentrated platinum salt reagent solution increased (Figure 5.19). The 
platinum surface coverage ranged from 20 to 180 Pt-containing molecules per 
nanoparticle. Control of the Pt coverage was therefore achieved by changing the 
concentration of the starting platinum reagent . This suggested that this reaction can be 
carried out with a great level of control, which is essential when developing multi-modal 




Figure 5.19. The platinum surface coverage on the nanoparticle as a function of the 
concentration of the starting reagent. 























5.5.3 Conjugation of Propargyl Folate and A Cis-Platinum Analogue in a One-Pot 
One-Step Approach 
 
 Having established that the nanoparticles can react with the potassium salt to yield 
a cis-platinum analogue at the surface, nanoparticles bearing both amine and azide 
functional groups were reacted with propargyl folate and potassium tetrachloroplatinate 
in a single-pot with both reactions being carried out in one step. Following completion of 
the reaction, the isolated nanoparticles were analyzed using FT-IR to monitor the 
presence of the propargyl folate, as well as XPS and ICP-AES to monitor the platinum 
loading on the nanoparticle surface. The FT-IR results are shown in Figure 5.20 for 
nanoparticles prepared using two different concentrations of propargyl folate reagent in a 
molar ratio of 0.1 and 0.2:1 folate:nanoparticles. Comparison of the four spectra yielded 
some important differences. Following the Click reaction of the alkyne-terminal of the 
propagyl folate and the azide groups decorating the nanoparticle surface, the azide (N≡N, 
2106 cm-1) and alkyne (C≡C, 2160 cm-1) stretches, observed in Figures 5.20a and d, 
respectively, were no longer observed in the spectra of the product (Figures 5.20b and c). 
This suggested that the reaction proceeded via the formation of the 1,3-dipolar 
cycloaddition product (inset of Figure 5.20). Several changes were observed in the 
spectra of the "clicked" nanoparticles (Figures 5.20b and c), especially at 1478 and 1404 
cm-1, where FT-IR bands were observed and attributed to the triazole ring C-N stretching 
and β in-plane C-H bending, respectively. Furthermore, peaks attributed to the presence 
of the propargyl folate (overlapping with the signals from the silica and silane reagents) 
were also observed at 1654 and 1609 cm-1. While a very weak band (observed as a 
shoulder) was observed for the carbonyl stretching at ~1700 cm-1 (Figure 5.20c), it is not 
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as intense as the other bands observed at 1654 and 1609 cm-1 and attributed to the 
pteroate ring stretching. While an the exact explanation for this observation is not yet 
certain, it may result due to the interaction of the C=O oxygen with the platinum metal 
resulting in a shift masked by the presence of the other bands in the FT-IR spectrum.   
 
 
Figure 5.20. FT-IR spectra of (a) amine and azide-modified nanoparticles, (b) propargyl 
folate (and cis-platinum) modified nanoparticles at 0.1:1 molar ratio 
(folate:nanoparticles), (c) propargyl folate (and cis-platinum) modified nanoparticles at 
0.2:1 molar ratio (folate:nanoparticles) and (d) propargyl folate.  
 
 Further investigation of the one-pot one-step product was carried out to determine 
whether the formation of the cis-platinum analogue had occurred. Using a 250 µL aliquot 
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of a 0.0215 M potassium tetrachloroplatinate solution on an amino silane decorated 
surface had resulted in ~180 Pt atoms per nanoparticle. On the orthogonally 
functionalized surface, ICP-AES analysis showed that the same quantity of starting 
material yielded 12 Pt atoms per nanoparticle, which is equivalent to a decrease of 90% 
to the amino silane-only decorated surface. This decrease in surface coverage was 
expected and attributed to the decrease in the amino surface groups (due to the presence 
of 50% azido silane reagent) as well as to steric effects brought about by the presence of 
the propargyl folate molecules. Increasing the volume of the potassium 
tetrachloroplatinate starting reagent four fold to a volume of 1000 µL (0.0215 M K2PtCl4 
concentration remains unchanged) yielded 48 platinum atoms per nanoparticle indicating 
that the linearity was maintained as a function of the amount of starting reagent. In 
addition, by XPS, the Cl:Pt ratio was also calculated and a value of 1.5:1 was observed. 
This value represented a slight decrease in the Cl:Pt ratio relative to the aminosilane-only 
decorated surface and may suggest that the bonding to the nanoparticle surface occurred 
via coordination to two or three surface amino groups.  The presence of an amine group 
on the pteroate ring might be expected to result in a coordination to the platinum species; 
however, it is noteworthy to mention that this amine group would less likely be prone to 
form a coordination bond with platinum due to the high extent of conjugation and the 
tautomerism of the pteroate ring system. The platinum species will therefore most likely 
preferentially coordinate to the free primary amines on the nanoparticle surface. 
 The presence of a folate derivative on the nanoparticle surface introduced the 
potential for targeting while the cis-platinum analogue would be considered as the 
therapeutic agent. Additional functionalities, such as imaging, are introduced to this 
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dual-mode system via the use of the optical properties of the upconverting nanoparticles. 
The luminescent properties of the lanthanide ions, particularly those with emission in the 
NIR, are of great interest for potential use in biological applications as they can be used 
for imaging. It is in this regards that folate/cis-platinum decorated silica-coated 
nanoparticles were prepared using a Tm3+/Yb3+ co-doped system.  
   
 
Figure 5.21. Digital photo image of the (a) blue upconversion emission and (b) NIR 
upconversion emission of Tm3+, Yb3+ co-doped upconverting nanoparticles. 
Upconversion emission spectra of (c) oleate-capped nanoparticles, (d) silica coated 








 Blue upconversion was observed at 450 and 479 nm and assigned to the 1D2 → 
3F4 and 1G4 → 3H6 transitions, respectively. Red emission assigned to the 1G4 → 3F4 
transition was centered at 650 nm. Finally, intense NIR emission emanating from the 3H4 
→ 3H6 transition was centered around 800 nm.  
 The mechanism of upconversion in Tm3+/Yb3+ co-doped NaGdF4 nanoparticles is 
shown below in Figure 5.22. A 980 nm source will raise the Yb3+ ion to its 2F5/2 excited 
state after which an energy transfer to the Tm3+ ion will occur. The excited Yb3+ ion will 
non-resonantly transfer its energy to a Tm3+ ion thereby exciting it to the 3H5 intermediate 
excited state after which non-radiative decay to the 3F4 excited state will occur. A second 
energy transfer from Yb3+ will occur raising the Tm3+ ion to the 3F2 excited state. The 
Tm3+ ion may either decay nonradiatively to the 3H4 state where 800 nm radiative 
emission will occur or alternatively, a third energy transfer can excite the Tm3+ ion to the 
1G4 state. At this point, there are several possibilities namely 1G4 → 3H6 blue or 1G4 → 
3F4 red emission may occur. Alternatively, a fourth energy transfer from Yb3+ populates 
the 1D2 excited state of Tm3+ after which blue emission is observed through the 1D2 → 
3F4 transition. 
 The luminescence of the Tm3+/Yb3+-doped nanoparticles persisted throughout the 
various synthetic modifications. Following silica coating, a decrease in the overall 
upconversion emission intensity was observed as seen in the normalized spectra in Figure 
5.21 (normalized to the blue emission at 450 nm). This was attributed to the efficiency of 
the silica phonons in bridging the energy gaps separating the various emitting levels of 
Tm3+. Finally, functionalization of the nanoparticle surface with the folate and cis-
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Figure 5.22. Energy transfer upconversion mechanism for NaGdF4:Tm3+/Yb3+ 







Chapter 6 - Multimodal Imaging Probes - Upconverting Nanoparticles 
for Optical and Magnetic Resonance Imaging 
 The concept of multimodality of nanoparticles refers to the ability of the 
nanoparticle system to carry out multiple functions for a given application as previously 
explained in Chapter 5. The system presented in the previous Chapter was multimodal as 
it was functionalized with multiple molecules on the surface potentially capable of 
carrying out multiple functions (targeting and therapeutic) as well as the fact that it can be 
used as an imaging probe due to the luminescent properties of the lanthanide ions. 
However, multimodality is not restricted to the capability of performing vastly different 
tasks meaning that even nanoparticles solely capable of imaging can in fact be considered 
multimodal. This arises from the fact that some nanoparticles can be used for more than 
one type of imaging. So far, only optical imaging has been discussed in this work; 
however, magnetic resonance imaging is another mode of imaging, which in recent years 
has been investigated for certain types of nanoparticles, especially those containing 
gadolinium ions in the matrix. 
 Gadolinium-based chelates are among the best and most used CAs for MRI 
imaging (other metals such as Mn2+, and Cu2+ have also been used); however, these 
chelates present several shortcomings. Firstly, only one Gd3+ ion can be chelated by the 
complex and hence the signal enhancement is restricted to a small local area. In addition, 
the circulation lifetime of these chelates is quite short [196, 197] and hence cannot be 
used for extended studies involving cell tracking for example. Another area of concern 
regarding gadolinium-based contrast agent complexes has been the leaching of free Gd3+ 
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ions from the complex and into the body resulting in toxicity [139, 140]. It is in this 
regard that there has been significant interest geared towards finding suitable alternatives 
to gadolinium-chelated CAs. In contrast to free or nanoparticle-bound gadolinium 
chelates, Gd3+-based inorganic nanoparticles offer several advantages. Firstly, the Gd3+ 
ions are tightly bonded in the inorganic crystal matrix and hence Gd3+ leaching is not 
likely to occur. Secondly, inorganic nanoparticles possess a high gadolinium-ion surface 
concentration. As a result, a significantly strong enhancement effect may be possible 
offering a potential alternative to current CAs [196-201].  
 
6.1 Sodium gadolinium Fluoride Nanoparticles - A New Class of CAs? 
 Sodium gadolinium fluoride nanoparticles are one class of nanoparticles currently 
under study as potential MRI CAs [196, 197, 200]. These nanoparticles discussed in 
Chapter 4 offer interesting morphological and luminescent properties with sizes that can 
be tailored from 10-80 nm. While the thermal decomposition technique investigated in 
Chapter 4 resulted in the formation of hydrophobic nanoparticles, hydrophilicity was 
achieved through a silica shell formation as was shown in Chapter 5. The use of a silica 
scaffold to render these nanoparticles hydrophilic for use as CAs is not necessary since 
these dual mode optical probes need not be functionalized with any additional molecules 
at the surface. Hence a capping ligand, such as tri-sodium citrate, which can endow a 
hydrophilic character to the nanoparticles can be used to exchange the hydrophobic oleate 





6.1.1 Oleate - Citrate Ligand Exchange 
 
 The exchange of the oleate molecules on the surface, with another ligand must be 
carried out in a thermodynamically favorable fashion, which would allow for the reaction 
to proceed. Citric acid is one molecule that can be used for the oleate ligand exchange as 
it possesses three carboxylic groups, which can bind to the nanoparticle surface and 
hence is a suitable candidate for the ligand exchange procedure.  
 The oleate ligand exchange process using citric acid or more appropriately the 
deprotonated form, trisodium citrate, is shown in Scheme 6.1. 
 
 
Scheme 6.1. Ligand exchange procedure whereby the oleate-capping ligand is replaced 
with trisodium citrate rendering the nanoparticle water dispersible. 
 
In the first step, the nanoparticles are dispersed in a non-polar solvent along with 0.2M 
trisodium citrate adjusted to pH 4. This pH corresponds to the pKa of the carboxylate 
group of oleic acid and hence following protonation of the COO- groups, oleic acid forms 
and can no longer cap the nanoparticle surface. Also at this pH, only one of the 
carboxylic acid groups of trisodium citrate is deprotonated and binds to the now-naked 
positively charged nanoparticle surface. At the onset of the experiment, a cloudy organic 
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phase containing the dispersed nanoparticles is shaken with a clear trisodium citrate 
solution (pH 4). After this step, there are several visual changes observed for this two 
phase mixture. Firstly, a cloudiness is observed in the aqueous phase due to the transfer 
of the nanoparticles in that phase following the loss of the oleate ligands. Secondly, the 
organic phase becomes clear indicating that the nanoparticles are no longer dispersed in 
this phase. Lastly, oleic acid is observed at the interface between the organic and aqueous 
phases. NIR excitation of the oleic acid or organic phases did not reveal any 
upconversion luminescence indicating the absence of the nanoparticles. Following 
purification of the isolated nanoparticles, re-dispersion in pH 7 adjusted citrate buffer is 
performed. At this pH level, all three carboxylate groups of trisodium citrate are 
deprotonated. Binding to the nanoparticle surface may therefore occur through two 
carboxylate moieties and may offer greater ligand-binding stability.  
 
6.1.2 Small and Ultra Small NaY(Gd)F4:Tm3+/Yb3+ Nanoparticles 
 
 The evaluation of gadolinium-based nanoparticles was carried out using a 
two-prong approach. Firstly, the effect of the nanoparticle size was evaluated with respect 
to the contrast enhancement performance. Secondly, the gadolinium concentration in the 
host was varied in order to identify the ideal gadolinium concentration that could 
potentially result in maximum contrast enhancement of an MRI image.  
 Hence for this study, two types of nanoparticles were prepared, namely 20 nm 
sized nanoparticles of NaY(Gd)F4:Tm3+ (0.5 mol%), Yb3+ (25 mol%). The concentration 
of Gd3+ in the host was varied as follows: 0, 1, 2.5, 5 and 74.5 mol%. At the lower 
concentrations, Gd3+ ions were substituted using Y3+ ions. The second type of 
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nanoparticles prepared were 5-nm sized NaGdF4: Tm3+ (0.5 mol%) and Yb3+ (25 mol%) 
nanoparticles. The interest in these ultra small nanoparticles stems from the fact the 
concentration of Gd3+ ions will increase at the surface as the surface area to volume ratio 
increases due to the particle size reduction. 
 Transmission electron microscopy analysis of the various batches, prepared  using 
Gd3+ concentrations ranging from 0-74.5 mol%, along with particle size distributions 
obtained from the TEM images are shown in Figures 6.1 and 6.2, respectively. 
 
 
Figure 6.1. TEM images of small NaY(Gd)F4:Tm3+ (0.5 mol%)/ Yb3+ (25 mol%) 
prepared using (a) 74.5 mol% Gd3+, (b) 5 mol% Gd3+, (c) 2.5 mol% Gd3+, (d) 1 mol% 





 TEM and particle size distributions (Figures 6.1 and 6.2, respectively) revealed 
that the prepared nanoparticles fell within a size range of 10-30 nm with the exception of 
the ultra small nanoparticles, which were determined to be <10 nm. The mean particle 
sizes of the various batches prepared are summarized in Table 6.1. The mean particle 
sizes ranged from 20-25 nm. This size similarity therefore allowed for direct comparison 
of the contrast enhancement behaviour in an MRI setting. The ultra small nanoparticles 
were determined to have a mean particle size of 3.7 ± 1.4 nm.  
 
 
Figure 6.2. Particle size distributions obtained from TEM images of small 
NaY(Gd)F4:Tm3+ (0.5 mol%)/ Yb3+ (25 mol%) prepared using (a) 74.5 mol% Gd3+, (b) 5 
mol% Gd3+, (c) 2.5 mol% Gd3+, (d) 1 mol% Gd3+, (e) 0 mol% Gd3+ and (f) 74.5 mol% 





Table 6.1. Mean particle sizes of small and ultra small NaY(Gd)F4:Tm3+/ Yb3+ 
nanoparticles.  
Nanoparticle Sample Mean Particle  Size (nm) 
74.5 mol% Gd3+ 23.0 ± 1.7 
5 mol% Gd3+ 24.4 ± 5.3 
2.5 mol% Gd3+ 20.7 ± 4.2 
1.0 mol% Gd3+ 21.2 ± 4.9 
0.0 mol% Gd3+ 19.7 ± 3.5 
74.5 mol% Gd3+  
(ultra small) 3.7 ± 1.4 
  
 Ligand exchange was carried out as outlined in Chapter 3 and Scheme 6.1, and the 
nanoparticles were analyzed using FT-IR spectroscopy. Shown below in Figure 6.3 is a 
comparison of NaGdF4:Tm3+ (0.5 mol%)/ Yb3+ (25 mol%)  nanoparticles pre and post 
ligand exchange with citrate molecules (comparisons are drawn to trisodium citrate). The 
citrate-capped nanoparticles showed bands at 1593 cm-1 and 1391 cm-1 corresponding to 
the symmetric and asymmetric stretches of the COO- groups. A broad O-H stretch was 
also observed at 3427 cm-1 due to the presence of a hydroxyl group on the citrate 
molecules. The band intensity of the C-H stretching bands at 2920 cm-1 and 2851 cm-1 of 
the oleate capping ligand diminished significantly following ligand exchange. The bands 
were nonetheless observed in the citrate-capped nanoparticle FT-IR spectrum and that is 
due to the presence of C-H stretches associated with the -CH2 groups of trisodium citrate. 
Furthermore, the free carboxylic acid stretching band at 1733 cm-1 (corresponding to 
unbound trisodium citrate with no electrostatic binding to the nanoparticle surface) was 
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not observed indicating that the observed stretches and vibrations were only due to bound 
citrate molecules to the nanoparticle surface. 
 
 
Figure 6.3. FT-IR spectra of (a) oleate-capped nanoparticles, (b) citrate-capped 
nanoparticles following ligand exchange with trisodium citrate and (c) trisodium citrate. 
   
 The nanoparticles prepared at low Gd3+ concentrations (≤5 mol% Gd3+) as well as 
ultra small nanoparticles (74.5 mol% Gd3+) were of the cubic crystal phase, whereas the 
small nanoparticle sample prepared at 74.5 mol% Gd3+ was of the hexagonal phase. The 
XRD results were similar to what was previously shown in detail in Chapter 4. The 
 
 























colloidal nanoparticles were probed using 980 nm excitation, and the upconversion 
luminescence was measured for both the oleate and citrate-capped nanoparticles. The 
upconversion emission spectra are shown in Figure 6.4. Oleate-capped nanoparticle 
dispersions, prepared in toluene, normalized to the 1G4 → 3H6 blue emission intensity of 
Tm3+  showed two main features most notably the stark increase in the NIR:blue emission 
ratio as a function of increasing Gd3+ concentration as well as a minor increase in the 1D2 
→ 3F4 blue emission centered at 450 nm. The increase in the NIR emission (1D2 → 3F4) is 
consistent with the increase in Gd3+ doping in the nanoparticles, which can likely lead to 
an increase in the hexagonal phase component and changes in the site symmetry favoring 
this transition. The ultra small nanoparticles also exhibited strong NIR:visible emission; 
however, this stems from the increase in surface defects on these sub-5 nm particles, 
which enhances the rate of non-radiative relaxation bridging the energy gaps separating 
the various transitions in the visible region of the spectrum. 
 Following the oleate ligand exchange with citrate molecules, the upconversion 
luminescence was re-evaluated for the aqueous dispersions. The upconverted 
luminescence was generally weaker in comparison to the  oleate-capped nanoparticles, 
dispersed in toluene. This is due to the high efficiency of the phonon energies of the 
hydroxyl groups of water at bridging the energy gaps separating the various states and 
increasing non-radiative pathways. The emissive properties of the nanoparticles were 
however similar and minor decreases in the blue and/or NIR emissions were noted with 
the exception of the NaGdF4 nanoparticles, which showed a more intense NIR emission 







Figure 6.4. Upconversion luminescence, following 980 nm excitation, of (a) 
oleate-capped and (b) citrate-capped small and ultra small NaY(Gd)F4:Tm3+/ Yb3+ 
nanoparticles bearing different Gd3+ ion concentration. 
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  In order to assess the contrast enhancement performance of these nanoparticles, 
dialysis was carried out to ensure minimum aggregation and remove any un-retained 
capping agent. This occurs while maintaining the colloidal dispersibility of the 
nanoparticles. Samples were retained under dialysis media in the membrane for a period 
of one week. Following dialysis of the nanoparticles, dynamic light scattering (DLS) 
analyses were carried out to obtain a measure of the particle size. Hydrodynamic 
diameters of nanoparticles coated with sodium citrate, and dialysed against 154 mM 
sodium chloride and 10 mM sodium citrate, were all in the range of 23-29 nm, while ultra 
small nanoparticles were 5.6 nm in diameter (Figure 6.5 and Table 6.2).  
 
 
Figure 6.5. DLS analysis of citrate-capped small and ultra small NaY(Gd)F4:Tm3+/ Yb3+ 
upconverting nanoparticles. 
 
 Following ligand exchange, an increase in the nanoparticle size was observed by 
















74.5% Gd3+ (ultra small) 
0%  Gd3+ 
1%  Gd3+ 
2.5%  Gd3+ 




measures a hydrodynamic diameter or the effective diameter in a liquid, accounting for 
factors such as the electric dipole layer, while in TEM, only the core diameter is 
measured. A summary of particle sizes measured by DLS post-dialysis is shown in Table 
6.2. 
 
Table 6.2. Hydrodynamic diameter of citrate-capped NaY(Gd)F4:Tm3+/Yb3+ 






74.5 mol% Gd3+ 29.1  
5 mol% Gd3+ 26.0 
2.5 mol% Gd3+ 22.6 
1 mol% Gd3+ 23.8 
0 mol% Gd3+ 23.4 
74.5 mol% Gd3+ 
(ultra small) 5.6 
  
 Dynamic light scattering stability studies were also carried out over a two-week 
period to confirm the colloidal stability of the citrate-capped nanoparticles (Figure 6.6). 
Dialyzed nanoparticle dispersions were measured at 0, 24 and 48 hours, 1 and 2 weeks. 
The hydrodynamic diameters measured over these time intervals did not show any 
significant differences relative to the as-dialyzed samples, suggesting that the colloidal 
dispersions of the citrate-capped nanoparticles were stable over this period of time. 
Moreover, dispersions of these citrate-capped nanoparticles prepared at 1wt% in water 
have been shown to remain in suspension for periods exceeding 3 months even when 
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stored at 5 °C. Following prolonged storage, the nanoparticles may be re-dispersed in the 





Figure 6.6. DLS evaluation of the stability as a function of time for citrate-capped 
NaY(Gd)F4:Tm3+/ Yb3+ (a) small and (b) ultra small upconverting nanoparticles prepared 










































  Dialysed nanoparticle dispersions were analyzed using XPS (Figure 6.7). This 
was carried out in order to investigate the elemental composition at the surface of the 
nanoparticles. The XPS results clearly showed the presence of fluorine, sodium, yttrium 
and gadolinium as expected. Significant peak overlap was however observed in the 
spectra of the nanoparticles. This was most evident in Figure 6.7b in the region of 130 to 
360 eV. Integrating the percent atomic ratios incurred large errors due to the overlap 
particularly for the Y 3d, Yb 4d and Tm 4d peaks. Hence, the integration for these 
elements was carried out from 160 to 220 eV without distinction between peaks. The 
concentration of yttrium was determined from the Y 3p peak from 299 to 325 eV and the 
Gd 4d peak was integrated from 130 to 160 eV. Integration of the peak areas of the 
elements was carried out in order to obtain a measure of the atomic ratio. The results are 


















Figure 6.7. XPS (a) wide-scan survey and (b) magnified region (130-360 eV) used for 
lanthanide detection of NaY(Gd)F4:Tm3+ (0.5 mol%)/ Yb3+ (25 mol%)  citrate-capped 
nanoparticles prepared using (i) 74.5 mol% Gd3+ (ultra small), (ii) 74.5 mol% Gd3+, (iii) 5 
mol% Gd3+, (iv) 2.5 mol% Gd3+ and (v) 0 mol% Gd3+. 
  
Table 6.3. XPS atomic chemical composition of NaY(Gd)F4:Tm3+ (0.5 mol%)/ Yb3+ (25 
















% (Yb4d + 
Tm 4d) 
74.5 mol% Gd3+ 7.4 1.5 13.5 - 11.9 54.7 11.0 
5 mol% Gd3+ 8.1 1.7 9.1 15.7 0.4 57.1 7.9 
2.5 mol% Gd3+ 9.93 4.55 7.04 17.13 0.22 53.21 7.92 
1 mol% Gd3+ 10.9 6.5 6.56 17.34 0.07 51.2 7.35 
0 mol% Gd3+ 8.4 7.2 7.9 15.1 - 53.3 8.1 
74.5 mol% Gd3+ 












 Some of the calculated atomic ratios (example Na:F, F:Gd or Na:Gd) differed 
from those expected based on the starting dopant composition. For example, the presence 
of sodium was lower than expected in comparison to the fluorine composition i.e. 1 
sodium for four fluorine atoms. These differences were however more prominent for 
samples containing low Gd3+ ion concentration (5, 2.5 and 1 mol% Gd3+). At the higher 
Gd3+ concentration (74.5 mol% smaller and ultra small nanoparticles), the stoichiometric 
ratios are in accordance with what is expected. Interestingly, the Gd:Y ratios follow the 
increase in Gd3+ ion concentration in the host matrix. In fact, plotting the Gd:Y ratio as a 
function of the theoretical Gd3+ ion concentration yielded a linear relationship (Figure 
6.8). It is important to highlight that the Gd3+ ions detected reflect the presence of these 
ions ~1-2 nm from the surface and that a decrease in detection of the elemental 
composition is expected with deeper probing. 
 A quantitative measure of the Gd3+ ion concentration was required prior to the 
evaluation of the contrast enhancement performance of the nanoparticles. Neutron 
activation studies were therefore carried out in order to determine the concentrations in 
the dialyzed suspensions. This technique is advantageous as (1) the sample analyzed can 
be in a solid, liquid or even in a precipitated form, (2) it is non-destructive and (3) the 
analysis is concerned only with the nucleus of an element [202]. In contrast, other 
techniques such as ICP-AES require sample digestion procedures in 10 mol% nitric acid, 
which are destructive to the sample with no possibility of recovery. In addition, these 
digestion procedures for the lanthanides can lead to a systemic underestimation of the 
lanthanide ion concentration in the dispersion [203]. Results of the neutron activation 





Figure 6.8. Correlation between the theoretical Gd3+ concentration (in mol %) and the 
Gd:Y ratio (in %) obtained from XPS analysis. 
 
  
Table 6.4. Concentration of fluorine, gadolinium, thulium, ytterbium and sodium ions in 















Gd3+ 299.11 73.05 3.99 24.33 1873.10 
      
5 mol% Gd3+ 186.21 2.55 0.41 17.05 75.82 
      
2.5 mol% Gd3+ 204.59 0.71 0.48 17.28 82.25 
      
1 mol% Gd3+ 106.31 0.14 0.24 9.25 51.44 
      
0 mol% Gd3+ 491.86 0.00 6.65 41.80 2447.66 
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The expected % molar ratios can be calculated from the neutron activation results for the 
various elements based on the expected stoichiometry. These calculations were in similar 
to the theoretical dopant concentrations. The samples obtained post dialysis can be 
regarded as unknowns and the data in Table 6.4 are only used to correlate the T1 and T2 
relaxation times to the concentration of the nanoparticles. This suggests that the 
nanoparticles do not need to be isolated from the dialyzed dispersions, dried and re-
constituted in order to determine the nanoparticle concentrations and to obtain the T1 and 
T2 relaxation profiles. Higher nanoparticle concentrations will result in correspondingly 
enhanced T1 and T2 relaxation but the relaxivity parameter, which is the slope obtained 
via the plot of 1/T1 or 1/T2 as a function of Gd3+ concentration, will remain unchanged.  
 Starting with the concentrated dialyzed dispersions (taken as 100%), dilutions of 
75, 50, 25, 10, 5 and 1% v/v were prepared and analyzed using time domain-NMR to 
measure the T1 and T2 relaxation profiles. The data analyzed were plotted as the inverse 
of either the T1 or T2 relaxation as a function of the Gd3+ ion concentration (obtained 
from neutron activation analysis) as shown in Figure 6.9 (plots shown for the 74.5 mol% 
Gd3+). The slope obtained from each plot corresponded to relaxivity 𝑟𝑖 of the contrast 








Figure 6.9. (a) T1 relaxivity and (b) T2 relaxivity plots for NaY(Gd)F4:Tm3+ (0.5 mol%)/ 
Yb3+ (25 mol%) citrate-capped nanoparticles prepared using 74.5 mol% Gd3+. 















y = 0.56x + 0.06
r2 = 0.9981




















 From the 𝑟1 and 𝑟2 values obtained from the slope of the plots, a ratio can be 
calculated by simply dividing 𝑟2/𝑟1. The resultant values can be used to determine 
whether the CA is best suited for T1 or T2-weighted analysis. As the value of the ratio 
approaches 1, the CA is ideal for T1-weighted scans whereas higher values (>6) are more 
suited for T2-weighted scans. The calculated 𝑟2/𝑟1 ratios are summarized in Table 6.5. 
 
Table 6.5. Calculated r2/r1 ratio obtained from the relaxivity plots for citrate-capped 




74.5 mol% Gd3+ 2.52 
5 mol% Gd3+ 2.74 
2.5 mol% Gd3+ 2.62 
1 mol% Gd3+ 4.13 
0 mol% Gd3+ N/A 
74.5 mol% Gd3+ 
(ultra small) 1.17 
 
 
 As the Gd3+ concentration decreased in the host matrix, an increase in the 𝑟2/𝑟1 
value was observed. This was expected as lower Gd3+ concentrations would imply fewer 
Gd3+ ions present for T1 contrast enhancement. At 1 mol% Gd3+ doping, the 𝑟2/𝑟1 ratio 
reached a value of 4.13 effectively suggesting that no T1 contrast enhancement could be 
achieved; however, a negative contrast enhancement may potentially be observed in 
T2-weighted scans. The 𝑟2/𝑟1 value of 4.13 approaches the values of 6-15 typically 
reported for commercial super paramagnetic iron oxide nanoparticles used in 
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T2-weighted MRI imaging [204].  
 Ultra small nanoparticles showed a very low 𝑟2/𝑟1 ratio with a value of 1.17. This 
value is similar to current commercial contrast agents which typically lie in the 1.1-1.2 
range [205] indicating that these nanoparticles can in fact provide comparable contrast 
enhancement in T1-weighted scans. It is important to re-emphasize that these ultra small 
nanoparticles offer several advantages relative to Gd3+-chelates. As previously 
mentioned, they contain Gd3+ ions that are tightly bound in the matrix and hence leaching 
of toxic Gd3+ ions does not represent a concern relative to chelated compounds. The latter 
have been known to cause nephrogenic systemic fibrosis in patients with renal disease 
[139]. Secondly, due to the high surface area to volume ratio, several Gd3+ ions are 
available for local contrast enhancement per nanoparticle as opposed to a single Gd3+ ion 
per chelate. 
 The 5-nm ultra small nanoparticles produced a significantly lower ratio in 
comparison to 30-nm sized (DLS size) nanoparticles prepared at the same Gd3+ 
concentration. This can be explained once again from the surface area to volume 
relationship discussed above and in Chapter 1. Ultra small nanoparticles will have a 
greater number of Gd3+ ions present at the surface/volume of nanoparticle relative to their 
30-nm sized counterparts. This translates to a greater number of interactions between the 
Gd3+ ions and the protons and ultimately an enhancement in the T1 image contrast.  
  Magnetic resonance imaging and contrast agent enhancement capability of these 
citrate-capped nanoparticle dispersions was evaluated in vitro. The dialyzed dispersion 
(considered the 100% stock) along with dilutions prepared at 50, 10 and 1% v/v were 
analyzed in an MR Scanner. Both T1 and T2-weighted analyses were carried out to assess 
163 
 
the contrast performance. Results for the NaY(Gd)F4:Tm3+ (0.5 mol%)/Yb3+ (25 mol%) 
citrate-capped nanoparticles prepared using 0, 5 and 74.5 mol% Gd3+ as well as ultra 
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Figure 6.10. 2-D spin echo images of NaY(Gd)F4:Tm3+ (0.5 mol%)/Yb3+ (25 mol%) 
citrate-capped nanoparticles prepared using 0, 5 and 74.5 mol% Gd3+ (a) T1-weighted 
image (TE/TR: 10.8/400 ms), (b) T2-weighted image (TE/TR: 50/3000 ms) and (c) ultra 
small citrate-capped nanoparticles prepared using 74.5 mol% Gd3+ T1-weighted image 
(TE/TR: 10.8/400 ms). Dilution series identified as 1, 10, 50, and 100% v/v. 
 
 Upon comparison of the T1-weighted MRI images in Figure 6.10, the 
NaY(Gd)F4:Tm3+ (0.5 mol%)/Yb3+ (25 mol%) citrate-capped nanoparticle dispersions 
prepared at 0 mol% Gd3+ showed no contrast enhancement as indicated by the grey spots 
observed for each of the tubes from most to least concentrated. A bright white spot would 
be expected as an indication for a positive T1 contrast enhancement. Evaluation of the T2 
contrast performance did not reveal any negative contrast enhancement, which would 
appear as black spots in the image in Figure 6.10. Increasing the Gd3+ ion concentration 
to 5 mol% revealed a positive contrast enhancement particularly for the sample at 50% 
v/v corresponding to a concentration of 3.1 mM of Gd3+. In addition, 5 mol% Gd3+ 
nanoparticles appeared to offer negative contrast enhancement in T2-weighted scans. 
Further increase of the Gd3+ doping in the matrix to 74.5 mol% also resulted in a positive 
contrast enhancement, which was only observed at the 10% dilution corresponding to a 
Gd3+ concentration of 1.9 mM. The 100% concentrated and 50% diluted samples did not 
show any contrast enhancement and that may be due to the high Gd3+ ion concentration 





in both dispersions. At very high concentration, there are likely Gd3+-Gd3+ through-space 
interactions, which may result in coupling between the Gd3+ ions. In this case, the Gd3+ 
ions may undergo a cooperative relaxation process, which will reduce the T1 contrast 
enhancement. This can be verified via examination of the T2-weighted images. This 
cooperative relaxation would result in an enhancement of the T2 image contrast and upon 
evaluation of Figure 6.10b, it is in fact the case. Both concentrated samples of the 
nanoparticles prepared using 74.5 mol% Gd3+ do produce a strong negative contrast. 
Interestingly, this effect was not observed in the ultra small nanoparticles. While these 5-
nm sized particles are also comprised of 74.5 mol% Gd3+, a positive contrast 
enhancement was observed even at the most concentrated samples. This difference can be 
related to the crystal phase of both small and ultra small nanoparticles. Small NaGdF4 
nanoparticles (23-29 nm DLS size, 74.5 mol% Gd3+) were observed to form in the 
hexagonal phase, while ultra small NaGdF4 nanoparticles (5.6 nm DLS size, 74.5 mol% 
Gd3+) were conversely observed to form in the cubic phase. The Gd3+-Gd3+ distance is 
shorter in the hexagonal phase with a value of ~363 pm relative to that in the cubic phase 
with a value of ~383 pm. This shorter distance likely results in significantly increased 
interactions [125] and may be used to explain the differences in the T1-weighted contrast 
enhancement results shown above.  
 Following the in vitro MRI assessment, a study was carried out to evaluate the 
contrast enhancement of both small and ultra small nanoparticles in vivo. Two sets of 
balb/c female mice were injected with dispersions of NaY(Gd)F4:Tm3+ (0.5 mol%)/Yb3+ 




Figure 6.11. In vivo MRI scan of balb/c female mice following injection with citrate 
capped NaY(Gd)F4:Tm3+ (0.5 mol%)/Yb3+ (25 mol%) nanoparticles (74.5 mol% Gd3+) 
with a size of (a) 29 nm and (b) 5.6 nm. Red arrows mark the abdominal aorta. Red circle 
marks the bright spot in the kidney. 
 
 
 An MRI scan was performed at t=0 prior to administration of the nanoparticle 
contrast agent through a tail vein injection. Following injection, the analysis was carried 
out at 15, 45, 90 minutes as well as 24 hours. Several differences were observed upon 
comparison of Figures 6.11a and b. The image contrast was observed to increase with 
time for the 29-nm sized small nanoparticles. This was mostly observed for the 
abdominal aorta (red arrow in Figure 6.11). The increase in contrast was most intense 
after 15 minutes and persisted up to the 90-minute time point. After 24 hours, no contrast 
enhancement was observed. This suggested that the nanoparticles were sequestered by 
the macrophages (likely within a 2-4 hour period) in the body and ultimately deposited in 





evidenced by the images in Figure 6.11b. A steady increase in positive contrast was 
observed even after 90 minutes suggesting that the half-life of these ultra small 
nanoparticles is on the order of several hours. In fact, 24 hours post administration, these 
nanoparticles appear to have continued circulating throughout the body indicated by the 
slight positive contrast observed in comparison to the image at t=0. An additional feature 
was noted for the ultra small nanoparticles as a bright spot in the kidneys of the injected 
mice. This was attributed to the passage of the ultra small nanoparticles through renal 
elimination routes to become excreted. No such observation could be made for the 29 nm 
sized small nanoparticles, which supported the hypothesis that these nanoparticles were 














Chapter 7 - Conclusions 
 
 The interest in nanoparticles has been strongly driven by the potential they hold. 
The integration of nanoparticles and nanotechnology in industrial and scientific 
applications has yet to reach its peak and this is certainly true for biological applications 
where nanoparticles can address several challenges associated with conventional 
fluorophores and provide much needed solutions. Lanthanide-doped nanoparticles may 
fulfill the above needs particularly in biological applications due to their interesting 
optical properties namely upconversion, as well as the flexibility in their surface 
chemistry. 
 The thermal decomposition of lanthanide-doped nanoparticles is a useful 
approach to synthesis as it can be used to tune the particle size to a specific need. The 
ability to generate monodisperse single phase colloidal nanoparticles in a range spanning 
10-80 nm suggests that this synthesis technique is versatile. While the resultant 
nanoparticles are hydrophobic in nature, imparting a hydrophilic character is essential for 
integration in biological applications. This can be carried out through surface 
modification, which will not only result in aqueous dispersibility, but may also be used as 
a platform for carrying out surface chemistry. 
 Achieving water dispersibility through silica coating introduces the 
aforementioned platform upon which nanoparticle surface chemical modification can be 
carried out. The orthogonal approach reported in this work differs relative to other 
surface modification techniques as it focuses on achieving control of the surface 
chemistry and the minimization of the number of steps required for modification. The use 
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of orthogonal chemistry ensures chemical specificity and minimizes side reactions. 
Furthermore, it enables the combination of several synthetic steps in a one-step, one-pot 
synthetic procedure. This approach was used to prepare multifunctional nanoparticles, 
which possess imaging, targeting and therapeutic capabilities. The functionality brought 
about through surface modifications is not limited to the molecules reported in this work, 
but can naturally be extended to other targeting and therapeutic agents, which can be 
integrated in other disease areas aside of cancer. 
 Lastly, the potential of lanthanide-doped nanoparticles extends beyond the surface 
modification capacities and beyond the optical imaging. Exploiting the paramagnetism of 
Gd3+ ions in the NaGdF4 matrix can lead to the development of novel contrast agents for 
magnetic resonance imaging applications. These nanoparticles especially at the sub-10 
nm size range, perform as well as chelated contrast agents yet offer a significant 
advantage in the form of added stability as the Gd3+ ions are tightly bound in the 
nanoparticle host. The surface area/volume ratio of these nanoparticles translates to a 
larger number of Gd3+ ions/volume available for local contrast enhancement in 
comparison to a single Gd3+ ion per chelate. 
 The work presented here aimed at achieving an understanding of the nanoparticle 
synthetic process and surface chemistry. In turn, this may offer a springboard from which 







Chapter 8 - Future Work 
 
 No research is complete without pondering future work to be conducted in an 
effort to further understand the systems studied. 
 With respect to the synthesis and characterization of NaGdF4 nanoparticles, it 
would be of great interest to evaluate additional points to the reaction parameters already 
investigated in order to create a database, which may be used to synthesize monodisperse 
nanoparticles of any size by simply "dialing in" the conditions required. 
 While this work has focused on NaGdF4, it would also be interesting to optimize 
the synthetic parameters of NaYF4 nanoparticles. The growth mechanism of NaYF4 has 
been reported to differ from that of NaGdF4 [30, 122, 143] and  hence, the synthetic 
parameters will likely differ between the two systems. Moreover, since NaYF4 
nanoparticles preferentially grow in the cubic phase [121], differences in the optical 
properties of the dopant luminescent ions would also be expected and can be exploited 
especially in multiplexing assays. 
   With regards to silica-coated nanoparticles, a further investigation of the 
orthogonal surface functionalization approach could prove useful. This work can be 
naturally extended to decorate the surface with other functionalities bearing alkyne 
(O-(propargyloxy)-N-(triethoxysilylpropyl)urethane), thiol ((3-mercaptopropyl) 
trimethoxysilane) or even carboxylate groups (carboxylethylsilanetriol sodium salt). 
Tri-surface functionalization can be orthogonally carried out with 3 different molecules 
such as azide, amine and thiol terminated molecules. These three molecules possess 
reactive specificities that can lead to the development of multimodal nanoparticles 
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capable of executing multi-pronged attacks. 
 It would also be important to evaluate the targeting, imaging and therapeutic 
capacities of the tri-modal system prepared in an in vitro or in vivo setting. In vitro cell 
work would be carried out to optimize the folate targeting ligand and platinum 
therapeutic agent concentrations in order to achieve the desired results in vivo. It is 
however anticipated that the therapeutic agent, in its current form, may not easily 
intercalate with DNA due to the presence of the nanoparticle (~20-30 nm in size). In 
order to mitigate this issue, the platinum analogue can be conjugated to the nanoparticle 
surface using a linker that is sensitive to cytosolic pH. This would ensure the release of 
the therapeutic payload once the nanoparticle enters the cell. 
 With respect to NaGdF4 nanoparticles for use as contrast agents, it would be 
interesting to further investigate Gd3+-Gd3+ interactions and their impact on the contrast 
enhancement in cubic and hexagonal NaGdF4. Tools such as molecular modeling can be 
used to model the coupling between the ions and cooperative behaviour leading to 
decreased contrast enhancement. In addition, it would be useful to investigate the effect 
of the capping ligand on the MRI performance. Polymer-capped nanoparticles will 
possess different physical properties relative to the citrate-capped counterparts. In 
particular, the tumbling rate of these nanoparticles can play a significant role in MRI 
contrast enhancement where slow tumbling rates will enhance the image contrast by 
further increasing the relaxivity values.  
 Also, as the upconversion luminescence is weaker at <10 nm particle sizes, it 
would be beneficial to evaluate ultra small core/shell nanostructures similar in size to the 
5 nm particles investigated in Chapter 6. An active or passive shell of NaGdF4 would 
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significantly enhance upconversion luminescence [206] without impacting the magnetic 




















Chapter 9 - Characterization and Experimental Techniques and 
Methods 
9.1 X-ray Diffraction  
 X-ray diffraction (XRD) patterns were measured using a Scintag XDS-2000 
diffractometer equipped with a Si(Li) Peltier-cooled solid state detector, CuKα source at 
a generator power of 45 kV and 40 mA, divergent beam (2 mm and 4 mm) and receiving 
beam slits (0.5 mm and 0.2 mm). Scan range was set from 20-80° 2θ with a step size of 
0.02° and a count time of 6 sec. All samples were measured using a quartz zero 
background insert disk. The patterns were analyzed according to the Rietveld method 
using the MAUD program under the assumption of isotropic peak broadening. 
 
9.2 Fourier Transform Infrared Spectroscopy 
 Fourier transform infrared (FT-IR) spectra were measured on a Nicolet FT-IR 
spectrometer. All solids were dried under vacuum for at least 24 hours prior to analysis. 
The solids were ground with KBr in a 1:10 ratio and were pressed to a thin wafer using a 
Specac press at a force of 10 tons. A KBr background was collected and used for all 
analyses. The background age did not exceed 1 hour. All samples were allowed to 
equilibrate inside the purged chamber for at least 15 minutes prior to analysis. The 
spectra in transmission mode were recorded using a wavenumber range of 4000-400 cm-





9.3 Transmission Electron Microscopy  
 Transmission electron microscopy (TEM) analyses of the colloidal nanoparticle 
dispersion were carried out using a Philips CM200 microscope operating at 200 kV 
equipped with a charge-coupled device (CCD) camera (Gatan). Prior to analysis, a 5 mg 
sample of nanoparticles was dispersed in 5 g of toluene to yield an approximate 0.1 wt% 
solution. A drop of the resulting solution was evaporated on a formvar/carbon film 
supported on a 300 mesh copper grid (3 mm in diameter).  
 
9.4 Inductively Coupled Plasma – Atomic Emission Spectroscopy 
 Inductively coupled plasma – atomic emission spectroscopy (ICP-AES) analysis 
of the platinum-loaded UCNPs was carried out using a Jobin-Yvon JY-2000. 
Approximately 10 µL of solution prepared in 10 mol% aqueous nitric acid was nebulized 
in the plasma flame. Analyses were repeated in triplicate to ensure good accuracy. 
Method development/optimization was carried out for platinum and showed that the ideal 
detection wavelength was 306.471 nm. All ensuing ICP analyses and calibration curve 
development for quantification were carried out at the optimized wavelength settings. 
Calibration curve samples were prepared in the concentration range of 0.01-10 ppm using 
APTMS functionalized nanoparticles and cis-platinum as the source standards. The 10 
ppm parent solution was prepared by weighing the appropriate amounts of the standards 
followed by their dissolution in 10 mol% nitric acid in a volumetric flask. All subsequent 
concentrations of 0.01-7.5 ppm were prepared via serial dilutions to minimize sample 
preparation errors. Unknown samples of lanthanide-doped nanoparticles functionalized 
with platinum were prepared in an identical fashion; however, the unknown solution 
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concentration was prepared at 200 ppm.  
 
9.5 X-Ray Photoelectron Spectroscopy 
 X-Ray photoelectron spectroscopy (XPS) analysis of cis-platinum, potassium 
tetrachloroplatinate, and platinum-loaded nanoparticles was carried out using an 
ESCALAB 2201-XL spectrophotometer, equipped with an Al Kα (1486.6 eV) 
monochromatic source at base pressures less than 10-8 Torr with a perpendicular take-off 
angle. Analysis of the raw data was carried out using CasaXPS software. All solids 
analyzed were previously dried under vacuum for at least 24 hours. The solids were 
immobilized on a double-sided sticky copper tape loaded on a glass substrate.   
 
9.6 UV Spectrophotometry 
 UV/Vis spectra were collected using a quartz cuvette (Helma, 1 cm path length) in 
a Cary spectrophotometer (Varian). All analyses were carried out at room temperature. 
Data was collected between 190-900 nm.  
 
9.7 1H NMR and 13C NMR 
 The 1H and 13C NMR spectra were acquired in 99.5% deutrated DMSO solvent 
using a Varian 500 MHz spectrometer. Propargyl folate was dissolved in the deutrated 
solvent at a concentration of 25 mg/mL and used for analysis. The spectrometer 





9.8 Optical Characterization of The Lanthanide-Doped Nanoparticles  
 The luminescent emission properties of the lanthanide-doped nanoparticles were 
measured following 980 nm excitation using a Coherent 6-pin fiber-coupled F6 series 
980 nm laser diode (maximum power of 800 mW at 1260 mA), coupled to a 100 μm 
(core) fiber. For the spectroscopic studies, the sample was dispersed in toluene (1 wt%) 
and placed in a Hellma, QS quartz cuvette (1 cm path length).  The upconverted visible 
emissions were collected at π/2 with respect to the incident beam and then dispersed by a 
1 m Jarrell-Ash Czerny-Turner double monochromator with an optical resolution of 
~0.15 nm. The visible emissions from the sample exiting the monochromator were 
detected by a thermoelectrically cooled Hamamatsu R943-02 photomultiplier tube. A 
preamplifier, model SR440 Standard Research Systems, processed the photo-multiplied 
signals and a gated photon counter model SR400 Standard Research Systems data 
acquisition system was used as an interface between the computer and the spectroscopic 
hardware. The digital cuvette images of the upconversion emission were taken using a 
Nikon D80 D-SLR camera equipped with an 18-135mm lens. The digital cuvette image 
of the NIR emission was measured using a Nikon D70 modified with a permanent 
infrared filter (wavelength cut-on 720 nm). A 900 nm cut-off filter was placed in front of 
the camera to avoid measuring the signal from the diode laser (λ = 980 nm). 
 
9.9 Dialysis of Citrate-Capped NaY(Gd)F4 Nanoparticles  
 Nanoparticle suspensions (5 mL) were dialyzed for 28 h in ultrapure water (18.2 
MΩcm) supplemented with 154 mM NaCl and 10 mM trisodium citrate, to eliminate free 
Gd3+ ions and excess citrate molecules. A membrane pore size of 1000MW (Spectra/Por 
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#6, Rancho Dominguez, CA) was used. The water was changed four times in the first 24h 
and the sample-to-volume ratio was kept to at least 1:1000. For ultra small particles, the 
last 4 hours of dialysis were performed in 154 mM NaCl and 1 mM trisodium citrate. 
After dialysis, the samples were transferred to a centrifuge-filter (Sartorius Stedim 
Biotech, Germany, pore size 0.2 μm, 3000g, 15 min). The dialyzed products for in vivo 
MRI and cell labeling studies were collected under aseptic conditions. 
9.10 Dynamic Light Scattering  
 The hydrodynamic diameter of as-dialyzed aqueous suspensions of nanoparticles 
was measured by dynamic light scattering (DLS, Malvern Zetasizer 173°, t = 25°C, in 
154 mM NaCl and 10 mM (small nanoparticles) or 1 mM (ultra small nanoparticles) 
sodium citrate). The analyses were performed at 25°C. The viscosity and refractive index 
of water were fixed at 0.8872 cP and 1.33. Five measurements were completed for each 
sample. For colloidal stability assessment, each sample was left at room temperature for 
at least one week, and measured at time points. 
 
9.11 Neutron Activation Studies 
 Neutron activation studies were carried out to determine the atomic concentration 
of the elements, which make up the chemical composition of the nanoparticles. Samples 
consisting of the dialyzed nanoparticle dispersions in de-ionized water and a sample with 
a 50% dilution factor were analyzed to determine the amount of F, Gd, Tm, Yb, Na in 
each suspension. Samples prepared in plastic Eppendorf tubes (0.5 mL) were introduced 
in the SLOWPOKE reactor for 100 seconds at a neutron flux of 1.0x1012 n.cm-2.s-1. The 
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24Na (T1/2 = 14.96 h),  20F (T1/2 = 11.46 s) , 169Yb (T1/2 = 32 d), 170Tm (T1/2 = 128.6 d) and 
153Gd (T1/2 = 280 d)  activities were all measured. Activities were corrected for decay 
time and after a period of 21 days, the vials were counted with a Ge(Li) detector for 1000 
seconds. 
 
9.12 1H NMR Relaxivity Studies and MRI Signal Measurements 
 Dilution volumes of 400 µL (100, 75, 50, 25, 10, 5 and 1 % v/v) of the dialyzed 
suspensions were distributed in 6.0 mm NMR tubes. Longitudinal and transversal 
relaxation times (T1 and T2) were measured with a dedicated TD-NMR relaxometer 
(Bruker Minispec 60 MHz, 25°C). The relaxation rates (1/T1 and 1/T2) were then plotted 
against Gd3+ concentration values, and relaxivities (r1 and r2) were calculated from the 
slope of the graphs.  
9.13 Magnetic Resonance Imaging and Contrast Agent Assessment  
 In vitro assays of the contrast agent performance were accomplished using a 1T 
ASPECT MR Scanner. A fast spin-echo MRI sequence was used to image samples of the 
citrate-capped nanoparticle suspensions. The samples were placed in a bowl of nanopure 
water. The following T1-weighted parameters were used: echo time: 10.8 ms, repetition 
time 400 ms, a flip angle of 90°; a field of view of 70 cm; 2.0 mm slice thickness, 200 x 
200 sample encoding NS number of excitations of 4.  
 
9.14 In vivo Signal Enhancement Profiles 
 Aliquots of the dialyzed small and ultra small (74.5 mol% Gd3+) suspensions were 
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dispersed in 154 mM NaCl (90% nanoparticle suspension, 10% 1.54 M aqueous NaCl), 
and vortexed. The stability of the particles was assessed by DLS, and T1 and T2, 
measured. All animal experiments were conducted under the guidelines of Université de 
Laval and Centre Hospitalier Universitaire de Québec's (CHUQ) animal ethical 
committee. Three 3-weeks old balb/c female mice (Charles River) were anaesthetised 
with isofurane using a nose cone on the MRI mouse bed. Animals were cannulated in the 
caudal tail vein, and connected to a catheter prewashed with heparin. Then, the animals 
were inserted in a dedicated 3.5 cm diameter RF coil, and MRI-scanned (1 T). Prior to 
injections the animals were scanned twice using a T1-weighted 2D spin echo sequence, 
with the following parameters: FOV: 90 mm, 24 slices, 0.7 mm, 0.1 slice gap, dwell time 
25 ms, 400x320, flip angle 90o, TE/TR: 18.3/851ms, duration: 4min 32sec. At time t = 0, 
the animals were injected with contrast media, and MR scans were performed in 
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